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Synthesis of carboxymethyl cellulose (CMC)-based bionanogels for dual 
stimuli-responsive drug release and cancer therapy 
Yifen Wen 
 
Polysaccharides possess great potential as building blocks in the development of drug 
delivery vehicles. This can be attributed to their outstanding virtues, such as biocompatibility, 
biodegradability, and possession of a plenty of functional groups. Their chemical flexibility 
allows for the modification of polysaccharides, leading to diverse functionalities that are 
valuable in biomedical applications. A promising functionality is stimuli-responsiveness that 
results in a change of physical or chemical properties of polysaccharide-based nanocarriers in 
response to an environmental change, such as pH, temperature, and light. Herein, recent 
strategies to develop polysaccharide-based nanomaterials for biomedical application are mapped 
out. Furthermore, using carboxymethyl cellulose (CMC) as a promising pH-sensitive 
polysaccharide, two types of stimuli-responsive polysaccharide-based nanomaterials were 
developed and evaluated as potential tumor targeting drug delivery nanocarriers.  
The first system involves dual pH/reduction responsive polysaccharide-based bionanogels 
(ssBNGs) prepared by aqueous crosslinking polymerization. CMC is grafted with pendant 
oligo(ethylene oxide) containing methacrylate (OEOMA), and crosslinked with a disulfide-
labeled dimethacrylate, yielding disulfide crosslinked ssBNGs with a diameter ≈ 24 nm 
measured by dynamic light scattering. ssBNGs exhibit dual pH/reduction-responsive drug 
release, attributed to less interactions between the encapsulated drug molecules and CMC at 
acidic pH and the reductive cleavage of disulfide crosslinkers. The possibility of conjugating a 
targeting ligand to ssBNGs is confirmed with a model water-soluble UV-active dye. 
The second system includes dual pH/temperature responsive bionanogels (DuR-BNGs). 
Thermoresponsive polymers undergo volume change above their lower critical solution 
temperature (LCST) due to a hydrophilic/hydrophobic transition. DuR-BNGs were prepared by 
grafting thermoresponsive monomers: di(ethylene oxide) methyl ether methacrylate (MEO2MA) 
and OEOMA from CMC in the presence of crosslinker via aqueous crosslinking polymerization. 
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The self-association of grafted P(MEO2MA-co-OEOMA) above their LCST resulted in a 
micelle-like structure of DuR-BNGs as well as narrow size distribution. DuR-BNGs exhibit pH-
responsive drug release due to the pH-dependent interaction of CMC with drug molecules. The 
temperature-responsive drug release was driven by the shrinkage of DuR-BNGs networks upon 
high temperature treatment, thereby expelling encapsulated cargoes causing rapid drug release. 
The non-specific protein absorption of DuR-BNGs is evaluated with bovine serum albumin 
(BSA) as a model.  
The potential application of two types of dual stimuli-responsive bionanogels (BNGs) in 
drug delivery is demonstrated with cell viability by MTT assay and cellular uptake using 
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Chapter 1  
Introduction 
 1.1 Overview of research and goals  
My Master’s research is aimed at exploring dual stimuli-responsive polysaccharide-based 
crosslinked nanogels (bionanogels) for enhanced/controlled release of anticancer drugs. A facile 
aqueous crosslinking polymerization method has been employed to synthesize two types of 
monodispersed bionanogels with diameter < 20 nm: redox/pH-responsive and pH/temperature-
responsive bionanogels. In response to dual stimuli, they exhibit rapid release of encapsulated 
anti-cancer drugs in cellular environment (in vitro). Furthermore, these smart bionanogels were 
evaluated as effective tumor-targeting intracellular delivery nanocarriers for cellular uptake and 
cell viability in HeLa cancer cell lines.  
1.2 General concepts of polymer-based drug delivery and research goals   
In cancer treatment, chemotherapy generally uses small anti-cancer therapeutic drugs, such 
as doxorubicin, paclitaxel, cytarabine and so on.[1] They are usually administered through 
intravenous (IV) injection. However, these small drug molecules are presented by two main 
challenges: low bioavailability and non-specific targeting.[2, 3] During blood circulation, small 
drugs are rapidly eliminated from the body through kidney filtration (called renal clearance), 
significantly reducing drug efficiency. Moreover, they quickly diffuse into normal tissues 
through undesired extravasation.[4, 5] This non-specific targeting causes cytotoxicity to normal 
cells, leading to dose-related side effects.[6] To circumvent these challenges facing small drugs, 
polymer-based drug delivery systems have been proposed. Typical example includes self-
assembled micellar aggregates, fibers, and crosslinked nanogels.[7, 8] Drug molecules are 
encapsulated in these nanomaterials through physical interactions or covalent attachments. The 
encapsulation can improve the solubility of hydrophobic drugs and protect drug molecules from 
deactivation.[3] More importantly, tumor tissues present irregularly-aligned vasculatures as a 
consequence of rapid growth in the process of cancer angiogenesis. [1, 5] The fenestration of 
endothelial cells in tumor vasculatures ranges at 300 - 4700 nm, promoting extravasation of 
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nanocarriers designed with their size of 50 - 150 nm to tumor tissues (enhanced permeability). 
Due to the lack of effective lymphatic drainages, the nanocarriers extravasated from blood 
circulation retain inside tumor tissues (retention).[5, 6, 9] This phenomenon is called Enhanced 
Permeability and Retention (EPR) effect, also referred as passive targeting (Figure 1.1), which is 
the main mechanism of nanocarriers for specific targeting to tumor tissues not to normal tissues.  
 
Figure 1.1. Illustration of EPR effect that allows nanocarriers to be accumulated in tumor tissues 
compared to normal tissues.[1]  
 
1.3 Polysaccharide-based drug carriers  
1.3.1 Polysaccharide  
Among diverse polymeric materials that are feasible for the construction of drug delivery 
nanocarriers, polysaccharides display unique advantages. Firstly, polysaccharides are naturally-
occurring biopolymers composed of one or more types of monosaccharides as repeating units 
connecting with glycosidic linkages.[10] Typical examples include hyaluronic acid, alginate, 
cellulose, chitosan, pullulan, and dextran (Figure 1.2). They are hydrophilic, intrinsically 
biocompatible, and widely exist in nature such as plants, animals, and bacteria.[11] Moreover, 
most of polysaccharides can be degraded by enzymatic reactions.[12]  The resulting degraded 
species are small to be removed from the body. Secondly, polysaccharides possess a variety of 
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reactive functional groups such as COOH, NH2, and OH groups. These groups can be used for 
the modification of polysaccharides toward effective biomaterials, particularly biocompatible 
nanocarriers.[13-15] For example, cellulose can be easily modified into its derivatives such as 
hydroxypropyl cellulose and carboxymethyl cellulose (CMC) with new functionalities.[16] 
Furthermore, the presence of functional groups can promote their bioconjugation with specific 
cell-targeting ligands for active targeting as well as facile conjugation with reactive synthetic 
polymers for new physical or chemical properties (e.g. hydrophobicity, surface charge, and 
stimuli-responsive property).[17-19] Thirdly, polysaccharides provide various physical properties 
such as molecular structure, hydrophobic/hydrophilic balance, and charge for various delivery 
applications. For example, β-cyclodextrin with seven glucopyranose rings can accommodate a 
wide variety of hydrophobic molecules through guest-host interactions to form inclusion 
complex.[20] Chitosan, a natural cationic polysaccharide, can bind to anionic phosphates in 
nucleic acids through ionic interactions to be useful as gene delivery nanocarriers.[21] These 
unique properties promote the use of polysaccharides as effective building blocks in the 
development of versatile bionanomaterials such as nanogels,[22, 23] self-assembled micelles,[24, 25] 
and hydrogels for biomedical applications.[26] 
 
Figure 1.2. Typical chemical structures of polysaccharides. Hyaluronic acid (HA), Alginate 




1.3.2 Polysaccharide-based bionanogels (BNGs) 
BNGs are defined as three-dimensionally crosslinked biopolymer-based networks that are 
confined into nanometer-sizes. They display great properties as drug delivery vehicles. Due to 
their hydrophilic polymer networks, BNGs possess high water content and good 
biocompatibility.[27] Because of being crosslinked, BNGs retain excellent colloidal stability upon 
dilution in blood after IV injection. Furthermore, their particle sizes can be adjusted from 10 to 
100 nm by the selection of synthetic strategies. Benefiting from their small particle sizes, 
bionanogels have large surface area and plenty of functional groups for surface modification.[10, 
11]  
In fact, the small particle size of BNGs plays a key role in efficient drug delivery. After 
bionanogels are injected into the body, BNGs should avoid multiple clearance mechanisms 
before reaching target sites.[28] Most of the clearance mechanisms are size-related. Renal 
clearance and urinary excretion rapidly eliminates nanoparticles with diameter <5 nm and MW 
<45 KDa.[29] Reticulo-endothelial system (RES) located in liver, spleen and lung enables 
recognizing and clearing nanoparticles that are larger than 200 nm.[8] Therefore, in order to 
minimize renal clearance as well as RES elimination, nanocarriers with the particle size ranging 
from 50 to150 nm would be an optimum size for drug delivery application.[5] 
1.3.3 Strategies of BNGs preparation  
The reported synthetic strategies can be classified into two methods: physical or chemical 
crosslinking. Physical crosslinking is mainly achieved via non-covalent interactions.[30] For 
example, chitosan−pentasodium triphosphate (TPP) nanogels were formed based on electrostatic 
interaction between positively charged amino groups of chitosan (in acidic pH) and phosphate 
anions of TPP.[31]  One limitation of physical crosslinking method involves the instability of 
nanogel networks due to weak interactions between polymeric chains. The formed BNGs are 
sensitive to environmental changes and can easily be destabilized. In contrast, chemical 
crosslinking involves the formation of covalent linkages of polymeric chains. A typical example 
to introduce covalent linkage is the use of external crosslinkers. For example, N,N’-methylene 
bisacrylamide (MBA) was used to prepare dextran-based crosslinked nanogels.[32] Another facile 
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way to introduce chemical linkages is through the modification of polymers with reactive groups 
such as carboxylic acid, amine, vinyl and thiol groups.[7]  
For the synthesis of well-defined BNGs, a water-in-oil (W/O) heterogeneous system is a 
typical technique. It consists of small water droplets stabilized by an oil-soluble surfactant 
dispersed in organic phase.[27] Polymerization and crosslinking occur simultaneously in the 
system, yielding BNGs with narrow size distribution. In order to maintain colloidal stability, a 
large amount of surfactants has to be used and then removed from BNGs.  
Compared to W/O heterogeneous systems, aqueous polymerization is a more convenient 
method that can be conducted under a mild condition with no use of surfactants. Because 
polymerization occurs in homogeneous medium, inter-particles crosslinking could lead to the 
occurrence of undesired aggregation.[33] In order to achieve uniform size distribution, several 
synthetic strategies have been proposed; the detailes will be discussed in Chapter 2. 
1.4 Stimuli-responsive polymeric nanomaterials 
Polymeric nanomaterials have been designed to release drugs through physical or chemical 
changes in response to stimuli (Figure 1.3).[34] These stimuli-responsive materials are also 
referred as “smart” materials. Internal stimuli are based on specific micro-environmental 
difference within tissues and cells, including redox potential, pH, temperature, and ionic strength. 
In contrast, external stimuli include heat, light, magnetic field, and ultrasound.[35] Once “smart” 
materials are subjected to the presence of stimuli, they undergo chemical degradation or physical 
change of volume. As a consequence, encapsulated drugs can be rapidly released from 
nanomaterials. Among numerous stimuli, pH, redox potential, and temperature have intrigued 
considerable attention because these micro-environmental differences exist between normal and 
pathological cells.[36] The constant gradient provides an effective driving force to trigger 




Figure 1.3. Typical example of stimuli-responsive drug delivery strategies.[35] 
1.4.1 Reduction-responsive degradation  
Reduction-responsive polymeric materials are promising biomaterials for controlled release. 
They are designed with reductively-cleavable linkages that can be broken in response to 
reduction reaction, resulting in the degradation of polymeric materials, thereby triggering rapid 
drug release. One of the typical redox-labile linkages is the disulfide bond (SS). It can be cleaved 
in the presence of glutathione (GSH), a cellular reducing agent, to the corresponding thiols.[37] In 
extracellular environment, GSH exists at < 2 µM, while it presents at ≈ 10 mM in intracellular 
environment. Compared to normal cells, GSH are found at elevated concentration in tumor 
tissues due to up-regulation metabolism of glutathione disulfide reductase.[35]  Such significant 
difference of redox potential between intra- and extracellular compartments in tumor tissues 
enables the rapid cleavage of disulfide linkages, thus leading to enhanced/controlled drug release 
(Figure 1.4). Typical methods to introduce disulfide linkages into biomaterials include 1) 
copolymerization of a disulfide-labeled crosslinker[33] and 2) thiol-disulfide exchange reaction to 




Figure 1.4. Reductive degradation of disulfide-containing bionanogels in response to cellular 
GSH.  
1.4.2 Temperature-responsive volume change 
Temperature gradient can be found between diseased and normal tissues.[39] Moreover, high 
temperature treatment (between 40 - 44 ºC), referred as hyperthermia, is commonly employed in 
cancer therapy to kill cancer cells while limit the effect to normal cells.[40] In response to a 
temperature change, thermoresponsive polymers undergo phase transition, causing volume 
change of nanocarriers, thereby triggering rapid drug release.[26] The thermoresponsive behavior 
can be characterized with lower critical solution temperature (LCST), which is the critical point 
where polymers undergo hydrophilic/hydrophobic transition (Figure 1.5). Below the LCST, 
polymers are hydrophilic and dissolved in water. Above LCST, polymers become hydrophobic 
due to the loss of H-bonding between polymers and water molecules.[41]  Thus, polymers collapse 
to form aggregates in water. LCST is also referred as a cloud point, which describes macroscopic 
thermal behavior of polymers.[42] The cloud point can be usually determined as an onset point of 
light scattering (LS) intensity of polymers in aqueous solutions. At above LCST, LS intensity 




Figure 1.5. Schematic drawing showing the phase transition associated with LCST.  
A typical thermoresponsive polymer is poly(N-isopropylacrylamide) (PNIPAM), whose 
LCST is 32 ºC close to body temperature. The LCST of PNIPAM can be adjusted by 
copolymerization of NIPAM with hydrophilic or hydrophobic monomers.[43] However, the 
cytotoxicity of NIPAM monomer presenting in PNIPAM could lead to potential biocompatibility 
issues, which limits its biomedical applications. Alternatively, PEO containing methacrylates 
such as poly(oligo(ethylene glycol) monomethyl ether methacrylate) (POEOMA) are analogs of 
PEO, which has good biocompatibility and capability of preventing non-specific protein 
absorption.[44] The LCST of POEOMA ranges from 20 to 80 °C, depending on the length of 
pendent ethylene oxide (EO) repeating units. Their LCST can be tuned by varying the component 
fraction of different OEOMA monomers (Figure 1.5).[45, 46]  
1.4.3 pH-responsiveness    
The physiological pH of body fluid is kept at 7.4. While cancer cells and inflammatory 
tissues are presented in a slightly acidic environment (pH ≈ 6.5) due to enhanced metabolic rates. 
Acidic pH is also found in cell organelles such as endosomes (pH ≈ 5.5) and lysosomes (pH ≈ 
5.0).[35] Such pH gradient can be used to trigger rapid drug release. 
Three approaches allow for introducing pH-sensitivity into nanocarriers. Approach I is to 
incorporate acid-labile linkages such as acetal, orthoester, imine, or hydrazone linkages, into 
nanogels.[34] In acidic pH, these acid-labile linkages are cleaved causing nanogel degradation. 
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Approach II is to introduce pH-dependent functional groups such as carboxylic acid or amine 
groups into nanogels.[47, 48] In response to pH change, nanogels undergo volume change, which 
can promote the diffusion of encapsulated cargoes.[49] Approach III involves the change in 
interactions between pH-sensitive nanogels and cargoes containing pH-sensitive groups, which 
also promote the enhanced drug release.[50]  
1.5 Scope of the thesis 
The purpose of this thesis is to provide a detailed study of preparing different dual stimuli-
responsive CMC-based BNGs as effective delivery nanocarriers for tumor-targeting enhanced 
drug release. A literature review focusing on recent strategies of synthesizing polysaccharide-
based nanomaterials is presented in Chapter 2.  
In Chapter 3, a dual pH/reduction-responsive bionanogel (ssBNG) containing pH-sensitive 
carboxymethyl cellulose (CMC) and disulfide linkages is reported. The proposed ssBNGs were 
synthesized by facile aqueous free radical polymerization in the presence of a disulfide-
containing dimethacrylate as a crosslinker. The enhanced drug release was examined upon acidic 
pH and reducing agent (a cellular trigger, glutathione). In response to acidic pH, the electrostatic 
interaction between CMC and encapsulated cargoes are decreased. Under the treatment of GSH, 
the cleavage of disulfide crosslinkers causes the degradation of polymer networks. The two 
mechanisms lead to enhanced drug release. Furthermore, the potential application of ssBNGs as 
drug delivery vehicles was evaluated through in vitro studies.  
In Chapter 4, another dual pH/temperature-responsive bionanogel (DuR-BNG) is presented. 
Temperature-responsive POEOMA were grafted from CMC in the presence of a permanent 
OEO-containing dimethacrylate crosslinker via aqueous polymerization. Micelle-like DuR-BNGs 
were synthesized through self-association assisted process. The resulting DuR-BNGs were 
evaluated for their prospective drug delivery applications. A significant enhanced drug release 
was achieved at temperatures above the LCST and in acidic pH. Furthermore, the DuR-BNGs 
had excellent colloidal stability and negligible non-specific interaction with proteins. 
Finally, conclusion and future directions to develop effective polysaccharide-based 
nanomaterials are presented in Chapter 5.  
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Chapter 2  
Review of recent strategies of developing polysaccharide-
based nanocarriers for biomedical application 
 
 
Polysaccharides are abundant in nature, renewable, nontoxic, and intrinsically biodegradable. 
They possess a high level of functional groups including hydroxyl, amino, and carboxylic acid 
groups. These functional groups can be utilized in further modification of the polysaccharides 
with small molecules, polymers, and crosslinkers; the modified polysaccharides have been used 
as effective building blocks in fabricating novel biomaterials for various biomedical applications 
as drug delivery carriers, cell-encapsulating biomaterials, and tissue engineering scaffolds. This 
review describes recent strategies to modify polysaccharides for the development of 
polysaccharide-based biomaterials; typically self-assembled micelles, crosslinked 
microgels/nanogels, three-dimensional hydrogels, and fibrous meshes. In addition, the outlook is 
briefly discussed on the important aspects for the current and future development of 
polysaccharide-based biomaterials, particularly tumor-targeting intracellular drug delivery 
nanocarriers. 
This chapter contains information that was published in Macromolecular Rapid 
Communications, 2014, 35, 1819-1832 and part of the chapter is reproduced from the article with 
the permission from the publisher. 
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2.1 Introduction  
Polysaccharides are naturally-occurring polymers or biopolymers. Typical examples of the 
polysaccharides include dextran (DeX), pullulan (PuL), cellulose (CeL), chitosan (CS), 
hyaluronic acid (HA), alginate (ALG), and many others (Figure 2.1a).[51-56] HA, as a main 
component of extracellular matrix, consists of N-acetyl-D-glucosamine and D-glucuronic acid. 
ALG composes of -D-mannuronic acid and α-L-guluronic acid residues. CeL, as a main 
component of plant cells, has been considered as the most abundant polysaccharide in nature. It 
consists of homopolymeric (1→4) linked of D-glucose. With a similar structure, CS is 
composing of (1→4) linked 2-amino-deoxy-D-glucan, resulting from the deacetylation of N-
acetyl-D-glucosamine of chitin (CT). It is almost the only cationic polysaccharide. PuL is a 
product of starch, formed of α(1→6) linked maltotriosyl units. DeX composes of α(1→6) 
glycosidic linkages between D-glucopyranose residues.[57] 
Polysaccharides are abundant in nature, renewable, nontoxic, intrinsically biodegradable, and 
relatively cheap. Furthermore, they possess a high content of functional groups including 
hydroxyl, amino (i.e. CS), and carboxylic acid groups (i.e. HA and ALG). These functional 
groups can be utilized for further modification of the polysaccharides. These features have 
attracted significant efforts to develop polysaccharide-based biomaterials for various biomedical 
applications as drug delivery carriers, cell-encapsulating biomaterials, tissue engineering 
scaffolds, and regenerative medicine.[27, 58-60] However, polysaccharides also have several 
drawbacks; they have broad molecular weight distribution and suffer from batch to batch 
variability. In addition, most polysaccharides including typically CeL, ALG, and CS have limited 
solubility in common organic solvents.[61] 
Toward those promising applications, various strategies utilizing well-defined organic 
synthesis and polymerization methods have been extensively explored; thus, the modified 
polysaccharides were used as effective building blocks to fabricate self-assembled micelles, 
crosslinked microgels/nanogels, three-dimensional hydrogels, and fibrous meshes. As examples, 
polysaccharides have been modified with small hydrophobic molecules or conjugated with 
hydrophobic polymers to render them to be amphiphilic for novel core/shell-type micellar 
aggregates. For the various forms of crosslinked materials (i.e. microgels, nanogels, and 
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hydrogels), polysaccharides have been crosslinked through chemical reactions or physical 
associations.   
In this review, we summarize the recent development of polysaccharide-based biomaterials 
with a focus on novel approaches for the modification of polysaccharides to synthesize self-
assembled micelles, crosslinked microgels, nanogels, hydrogels, and fibrous materials for bio-
related applications. This review focuses on the polysaccharides in linear structures shown in 
Figure 2.1. Cyclodextrin (CD)-based supramolecular assemblies and hydrogels with the focus on 
recent advances are summarized in a recent review[62] and other reports.[63] In addition, 
polysaccharide-based hybrid materials containing inorganic metal nanoparticles[64-66] and carbon 
dots[67] are not covered in this review.  
 
Figure 2.1. Chemical structures of typical polysaccharides and polysaccharide-based 
biomaterials, typically self-assembled micelles, crosslinked microgels/nanogels, three-
dimensional hydrogels, and fibrous meshes, for various biomedical applications such as drug 
delivery, cell-encapsulation, tissue engineering, and regenerative medicine. Abbreviation of 
polysaccharides) DeX: dextran, PuL: pullulan, CeL: cellulose, CS: chitosan, ALG: alginate, HA: 
hyaluronic acid, HPCeL: hydroxypropyl cellulose, ECeL: ethyl cellulose, CMC: carboxymethyl 




2.2 Polysaccharide-based self-assembled aggregates 
For the preparation of self-assembled micellar aggregates, the modification of 
polysaccharides (hydrophilic or water-soluble) with hydrophobic species is required, yielding 
amphiphilic polysaccharides. The hydrophobic species for the modification are small molecules, 
oligomers, or high molecular weight polymers which bear reactive functional groups. The 
resulting amphiphilic polysaccharides self-assemble to form micellar aggregates in aqueous 
solutions, consisting of hydrophobic cores surrounded with polysaccharide coronas. A variety of 
novel strategies have been explored to synthesize amphiphilic polysaccharide-based micellar 
aggregates. 
2.2.1 Amphiphilic polysaccharides modified with small hydrophobic molecules 
Various small hydrophobic molecules have been conjugated to polysaccharides to yield 
amphiphilic polysaccharides. An example includes the conjugation of HA with hydrophobic 
aminoethyl 5-cholanomide having a terminal amino group, derived from 5-cholanic acid, 
through a carbodiimide coupling reaction. The resulting amphiphilic HA self-assembled to form 
micellar aggregates surrounded with HA coronas with a diameter = 350 - 400 nm as potential 
drug delivery nanocarriers.[68] Other examples include the synthesis of HA conjugated with 
cholesteryl group,[69] DeX conjugated with terpene (an extract from resin produced by conifer 
trees),[70] DeX tethered with doxorubicin (Dox; a clinically-used anticancer drug),[71] and several 
others.[72, 73] The Dox-conjugated DeX as a biopolymer-based prodrug exhibits improved tumor 
penetration. These examples of amphiphilic polysaccharides involve the covalent conjugation of 
polysaccharides with hydrophobic molecules through strong covalent linkages. 
In contrast, an introduction of stimuli-responsive cleavable linkages into the design of 
amphiphilic polysaccharides allow for the synthesis of amphiphilic nanocarriers that can be 
degraded in response to external triggers (degradable amphiphilic polysaccharides). Such stimuli-
responsive cleavage of the labile linkages facilitates the controlled/enhanced release of 
encapsulated drugs. Examples include an acid-labile cholesteryl-modified PuL[74] and a 
reduction-responsive Dox-conjugated DeX.[75] Recently, amphiphilic PuL was synthesized by 
conjugation of pH-sensitive urocanic acid and hydrophobic cholesterol succinate to PuL (Figure 
2.2). It self-assembled to form micellar aggregates with a diameter = 150 - 300 nm. Due to the 
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presence of pendant urocanic acids, the amphiphilic PuL micelles exhibited pH-responsiveness 
with swelling/deswelling transition at around pH 6.5. Such pH-responsiveness enabled to 
enhance intracellular release of encapsulated anticancer drugs, evidenced by cell viability, 
confocal laser scanning microscopy, and flow cytometry.[76] 
 
 
Figure 2.2. Synthesis, self-assembly, and pH-responsive release of amphiphilic PuL conjugated 
with urocanic acid and cholesterol succinate via a carbodiimide coupling reaction. Reproduced 
with permission.[76] Copyright 2014, Royal Society of Chemistry.  
2.2.2 Amphiphilic polysaccharides conjugated with polymers 
Numerous approaches have been explored to synthesize polymer-conjugated polysaccharides. 
One approach is the synthesis of diblock polysaccharides (i.e. polysaccharide-b-polymer) where 
one end of polysaccharides is directly attached to one end of synthetic polymers. This approach 
requires the modification of polysaccharides to have terminal reactive groups. For example, 
glycosaminoglycan was oxidized to have terminal aldehyde groups, which were involved in 
oxime click reaction to form glycosaminoglycan-b-poly(ethylene glycol) (PEG) block 
copolymers. These anionic copolymers enabled to form micelloplexes through ionic interactions 
with cationic poly(L-lysine) (PLL), a model protein; the resulting micelloplexes can be useful as 
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delivery vehicles for positively charged proteins.[77] However, most approaches involve the 
synthesis of polymer-grafted polysaccharides though “grafting from” and “grafting to” methods.   
The “grafting from” method employs novel polymerization methods such as ring opening 
polymerization (ROP),[78, 79] controlled radical polymerization (CRP),[80] or oxidative 
polymerization.[81] Well-defined synthetic polymers with narrow molecular weight distribution 
(Mw/Mn < 1.4) can be grown from polysaccharide chains, yielding polymer-grafted 
polysaccharides (polymer-g-polysaccharides). ROP is utilized to synthesize biodegradable 
aliphatic polyesters such as polylactide (PLA), polycaprolactone (PCL), polyglycolide (PGA), 
and their copolymers grafted from polysaccharides. Pendant hydroxyl (OH) groups in 
polysaccharides are generally used as initiating species for the ROP of the cyclic monomers. 
Typical examples include CeL-g-PCL,[82] DeX-g-PCL,[83] CeL-g-(PCL-b-PLA),[84] HPCeL-g-
PCL.[85] CRP is utilized to synthesize poly(meth)acrylates grafted from polysaccharides. Typical 
CRP methods that have been explored include atom transfer radical polymerization (ATRP)[86, 87] 
and reversible addition fragmentation chain transfer (RAFT)[88, 89] polymerization. The pendant 
OH groups in polysaccharides are modified to convert the corresponding initiating moieties such 
as bromines for ATRP and dithiocarbonyl groups for RAFT polymerization. The detailed 
synthesis of various polysaccharide-g-polymethacrylates using CRP methods is described in the 
previous review.[90] 
 The “grafting to” method utilizes well-known organic reactions such as click-type or 
condensation reactions of polysaccharides with pre-synthesized polymers. The click-type 
reactions are highly selective and orthogonal, thus resulting in quantitative conversion under mild 
conditions.[91-93] A typical click-type reaction is 1,3-cycloaddition of alkynes and azides in the 
presence of Cu(I) complexes.[94, 95] This reaction has been utilized after the modification of 
polysaccharides with pendant alkyne or azido groups. The modified polysaccharides then react 
with polymers in the presence of Cu(I) complexes, yielding brush-like, amphiphilic 
polysaccharides. Most reports describe the modification of polysaccharides including CD,[96] 
oligosaccharide,[97] ECeL,[45] and CS[98] with azido groups. The resulting azido-containing 
polysaccharides reacted with alkynyl-labeled PEG, PLA, PCL homopolymers, and their 
copolymers. As a typical example, Figure 2.3 illustrates an approach to synthesize amphiphilic 
ECeL grafted with thermoresponsive polymethacrylates. ECeL was first modified with 2-
bromoisobutyryl bromide to form 2-bromoisobutyryl ECeL (ECeL-Br) via a simple 
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esterification, followed by its reaction with sodium azide (NaN3), yielding ECeL-N3. Meanwhile, 
well-defined alkynyl-poly(N,N-dimethylaminoethyl methacrylate) (alkynyl-PDMAEMA) and 
alkynyl-poly(di(ethylene oxide) monomethyl ether methacrylate (DEGMA or MEO2MA) -co-
oligo(ethylene oxide) monomethyl ether methacrylate (alkenyl-P(MEO2MA-co-OEOMA)) were 
synthesized by ATRP in the presence of an alkenyl-labeled bromine ATRP initiator. These 
thermo-responsive (co)polymers were grafted to ECeL-N3 via the click reaction. The resultant 
ECeL-grafted copolymers were double-hydrophilic, thermoresponsive; thus, they self-assembled 
at temperatures above LCST to form aqueous aggregates.   
 
Figure 2.3. Synthesis of amphiphilic brush-like ECeL grafted with thermoresponsive 
(co)polymers. Reproduced with permission.[45] Copyright 2012, Elsevier.  
 
Another click-type reaction is Michael addition reaction. Thiol-ene Michael addition[99-102] 
has been explored to synthesize a thermoresponsive HA-polymer conjugate, thus HA-g-
P(DEGMA-co-OEOMA) (Figure 2.4).[23] A pendant maleimide-labeled HA was synthesized by 
reaction of HA with aminoethylmaleimide. A thiol (HS)-terminated P(DEGMA-co-OEOMA) 
was separately synthesized by RAFT polymerization, followed by aminolysis of terminal RAFT 
agent in the presence of a primary base. Two polymers reacted via a base-catalyzed Michael 
addition reaction. The resulting HA-g-P(DEGMA-co-OEOMA) exhibited tunable 
thermoresponsive properties with varying amounts of thermoresponsive P(DEGMA-co-
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OEOMA) block. Furthermore, they self-assembled to form aggregates as a consequence of the 
hydrophobic transition of P(DEGMA-co-OEOMA) block at above LCST.  
Facile coupling reactions have also been reported to synthesize amphiphilic polysaccharides. 
Typical examples include HA-g-PLGA in the presence of dicyclohexyl carbodiimide,[103] CD 
grafted with PEO-b-PCL in the presence of N,N-carbonyl diimidazole (CDI),[104] -CD grafted 
with PCL-b-PEO-b-PCL triblock copolymer,[105] and HA grafted with a thermoresponsive 
polymer.[106] Recently, PCL was grafted to HA through a carbodiimide coupling reaction to form 
PCL-HA, which self-assembled to form anionic micelles in physiological conditions. The anionic 
HA coronas were ionically interacted with cationic CS to form CS/PCL-HA polyelectrolyte 
complex aggregates for oral delivery.[107]     
 
Figure 2.4. Synthesis of a thermoresponsive HA-polymer conjugate of HA-g-P(DEGMA-co-
OEOMA) via thiol-ene Michael addition reaction and their self-assembly driven by change in 
temperature. Reproduced with permission.[23] Copyright 2012, Royal Society of Chemistry.  
 18 
 
2.3 Polysaccharide-based crosslinked microgels/nanogels  
For targeted drug delivery applications in vivo, a challenge of physically aggregated micelles 
is to retain their colloidal stability upon dilution. After in vivo injection, drug loaded micelles are 
significantly diluted by several orders of magnitude in the blood. As a consequence, the micelles 
are subjected to local environment far below the critical micellar concentration. The dilution 
could result in dissociation of micelles, leading to the premature of encapsulated cargoes. Several 
strategies have been explored, including the design of block copolymers with lower critical 
micellar concentration[108] and brush-like graft copolymers.[109] A promising strategy is to 
introduce effective crosslinking chemistry into the synthesis of crosslinked nanogels/microgels 
based on polysaccharides. The microgels are a class of three-dimensionally crosslinked hydrogels 
confined in micrometer-sized particles; when the microgels are nanometer-sized, they are known 
to be nanogels.[57]  
2.3.1. Chemical crosslinking by condensation  
This method centers on the synthesis of reactive polysaccharides grafted (or conjugated) with 
small molecules or polymeric chains bearing reactive functional groups. These reactive groups 
are then involved in the crosslinking reactions to form polysaccharide-based microgels/nanogels 
in aqueous solutions. HPCeL was modified with poly(acrylic acid) (PAA) by multiple steps; 1) 
ROP of CL, 2) esterification of the resulting PCL-grafted HPCeL to the corresponding bromide, 
and 3) chain extension with poly(t-butyl methacrylate) (PtBMA) by ATRP, yielding HPCeL 
grafted with PCL-b-PtBMA block copolymer. The following hydrolytic cleavage of t-butoxy 
groups to the COOH groups yielded reactive HPCeL grafted with PCL-b-PAA block copolymers. 
The pendent COOH groups reacted with amino groups of external crosslinkers, allowing for the 
synthesis of nanogels crosslinked with amide linkages in water.[110] PuL was also modified with 
vitamin B6 (pyridoxal) by an alkyne-azido click-type reaction to yield pyridoxal phosphate-
bearing PuL having aldehydes. The reactive PuL was crosslinked with a protein (lysozyme) 
containing several amino groups through a Schiff-base reaction with reactive aldehydes in 
aqueous solution.[111] However, these nanogels could have broad size distribution due to the 
occurrence of crosslinking in aqueous solution (not in compartmentalized locations). For the 
preparation of well-defined nanogels with narrow size distribution, the control of concentrations 
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could be important to minimize of undesired inter-chain crosslinking reactions, which leads to the 
occurrence of large aggregation.   
A promising approach to narrow size distribution utilizes self-assembly driven by either 
amphiphilicity or temperature-change, followed by chemical crosslinking reactions. For the 
approach, polysaccharides are first modified to be amphiphilic or thermoresponsive; the resulting 
amphiphilic polysaccharides bearing reactive functional groups self-assemble in aqueous solution 
to form reactive micellar aggregates. For example, PuL was conjugated with hydrophobic 
cholesterols and reactive groups. The resulting reactive amphiphilic PuL self-assembled to form 
nano-assemblies with a diameter = 18 nm in aqueous solution. The reactive acrylate groups were 
then involved in interparticle crosslinking with a thiol-terminated 4-arm star PEG crosslinker 
through thiol-ene Michael addition reaction, yielding raspberry-like nanogels with diameter 
ranging from 40 to 120 nm by varying the initial ratio of [SH]0/[acrylate]0 groups. The resulting 
nanogels exhibit the prolonged release profile of encapsulated proteins.[112] HA was also modified 
with pendant hydrophobic pyrene moieties and reactive hydrazine (-C(O)-NH-NH2) groups. The 
reactive HA self-assembled to form aqueous micellar aggregates, and further stabilized by 
chemical crosslinking (through the formation of hydrazones) of HA chains to form HA-based 
nanogels.[113] 
2.3.2. In situ disulfide-crosslinking method 
Covalent crosslinking strategy provides enhanced colloidal stability against dilution. 
However, the use of permanent crosslinkers hampers enhanced/controlled release of encapsulated 
drugs. An introduction of stimuli-responsive degradation strategy of dynamic covalent bonds 
(cleavable linkages) in response to external stimuli enables the enhanced drug release.[114-116] In 
contrast to the addition of external crosslinkers bearing cleavable linkages, in situ disulfide-
crosslinking method is more promising in that the method results in the formation of reduction-
responsive disulfide dynamic covalent bonds as crosslinks through two ways: disulfide-thiol 
exchange reaction and oxidation. The resulting disulfide-crosslinked nanogels exhibit enhanced 
colloidal stability as well as promoted drug release in response to reduction reactions.  
For the disulfide-thiol exchange reaction, polysaccharides were modified with pendant 
disulfide linkages. For example, lipoic acid (LA) was conjugated to starch[24] and DeX[117] to 
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form LA-starch and LA-DeX, which self-assembled to form micellar aggregates. The partial 
cleavage of disulfides in response to a catalytic amount of D,L-dithiothreitol (DTT), a reducing 
agent, resulted in the formation of disulfide-crosslinked nanogels. These nanogels having 
enhanced colloidal stability as well as reduction-responsive promoted drug release have a 
potential for tumor-targeted chemotherapy. 
For oxidation of pendant thiol groups of copolymers, different strategies have been explored 
to introduce pendant thiol groups into polysaccharides. A RAFT polymerization and following 
aminolysis has been examined. The RAFT polymerization allowed for the chain extension of 
PuL[19] and DeX[38] with PNIPAM, yielding PNIPAM-grafted polysaccharides. The following 
aminolysis of terminal RAFT agents in the presence of a primary amine resulted in the synthesis 
of pendant HS-terminated PNIPAM-grafted polysaccharides. At a temperature above the LCST, 
they self-assembled upon temperature change to form pendant thiol-functionalized micelles, and 
further to temperature responsive disulfide-crosslinked nanogels upon oxidation. A facile 
coupling reaction was also examined for the reaction of cysteamine with HPCeL activated with 
4-nitrophenyl chloroformate (4-NC) (Figure 2.5). The resulting thiolated HPCeL (HPCeL-SH) 
was collapsed to form nanospheres upon the LCST transition. The pendant SH groups in the 
nanostructures were then oxidized by DMSO, yielding disulfide-crosslinked nanogels with 
diameter = 72 - 88 nm.[118] These disulfide-crosslinked nanogels exhibited reduction-responsive 




Figure 2.5. Synthesis, self-assembly at temperature above LCST, and oxidation of thiolated 
HPCeL to form disulfide-crosslinked nanogels. Adapted with permission.[118] Copyright 2011, 
Royal Society of Chemistry.  
2.3.3. Aqueous free radical crosslinking polymerization (FRCP) 
Aqueous FRCP has been explored to synthesize polysaccharide-based nanogels crosslinked 
with vinyl polymers (including polymethacrylates). An approach includes the functionalization of 
polysaccharides with methacrylate moieties. The resulting methacrylated polysaccharides are 
used as multifunctional crosslinkers for FRCP.[119] Oil-in-water inverse miniemulsion 
polymerization has been widely explored to synthesize crosslinked nanogels with narrow size 
distribution due to the occurrence of polymerization in compartmented locations (i.e. inverse 
miniemulsion).[120] Recently, this approach has been advanced to synthesize enzymatically 
degradable nanogels by inverse miniemulsion polymerization of acrylamide (AAm) with a 
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methacrylated-modified DeX crosslinker.[121] Furthermore, the interesting technique has been 
explored for the synthesis of dual enzymatic and light-degradable nanogels (Figure 2.6).[122] 
 
Figure 2.6. Schematic representation of dual enzymatic and light-degradable nanogels 
crosslinked with photo-labile linkage of DeX-g-PAAm. Reproduced with permission.[122]  
 
Another approach utilizes aqueous FRCP of vinyl monomers in the presence of 
polysaccharides, resulting in the formation of vinyl polymer-grafted polysaccharides. By varying 
the vinyl monomers, the properties of the grafted polysaccharide can be tuned. Typical examples 
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of grafted vinyl polymers include PAA for pH response[123] as well as PNIPAM and PAAm for 
temperature response.[124, 125] In the presence of difunctional crosslinkers, this approach allows for 
the synthesis of crosslinked nanogels such as PNIPAM-grafted CS nanogels.[126-128] Oridon 
known to be an anticancer agent against liver cancers was loaded into pH-responsive nanogels 
decorated with galactose ligands. These nanogels show the potential for hepatoma-targeted 
delivery.[126] Recently, glucose-responsive nanogels based on poly(acrylamidophenylboronic 
acid) (PAAPBA) were synthesized by a self-assembly assisted strategy. This method utilizes 
thermoresponsive properties of PAAPBA; during polymerization at temperatures above LCST, 
PAAPBA-grafted DeX in the presence of difunctional crosslinker self-assembled to form well-
defined nanogels. Since boronic acid moieties incorporated in the nanogels recognize glucose, the 
nanogels can be useful as potential glucose sensor.[32] More recently, new dual stimuli reduction 
and acidic pH-responsive nanogels were developed by a facile aqueous FRCP of OEOMA in the 
presence of CMC and a disulfide-labeled dimethacrylate crosslinker (ssDMA). As show in Figure 
2.7, the nanogels are crosslinked with reductive-responsive disulfide linkages of POEOMA-
grafted CMC, exhibiting enhanced release of encapsulated anticancer drugs to dual responses: 
reductive cleavage of disulfide crosslinkers and acidic pH responsive of COOH groups in CMC. 
The intracellular release of anticancer drugs after internalization into HeLa cancer cells, 
combined with the ability to facile bioconjugation suggest as a promising intracellular 




Figure 2.7. Synthesis and dual reduction and acidic pH-responsive Dox release of nanogels 
crosslinked with disulfide linkages of POEOMA-grafted CMC.[33] Copyright 2014, Royal Society 
of Chemistry.  
2.3.4. Physical crosslinking method 
In contrast to chemical crosslinking that allows for the formation of covalently-crosslinked 
nanogels, physical crosslinking yields supramolecular nanogels by utilizing non-covalent 
interactions between polysaccharides and external crosslinkers. Of these interactions including 
stereocomplexation of PLA-based DeX[129] and host-guest molecular recognition of DeX,[130, 131] 
the ionic interaction has been widely explored to synthesize polysaccharide-based nanogels. 
Without further modification, CS possessing pendant amino groups interacted with anionic 
crosslinkers such as tripolyphosphate (TPP)/ALG (containing pendant COOH groups) for ionic 
gelation. The resulting CS/TPP/ALG nanogels were evaluated for insulin release[132] or cell 
response;[133] however, they had relatively large diameters (d > 250 nm) due to the formation of 
more expanded structures. Such a large size could have a short blood circulation due to uptake by 
RES. A smaller sized CS-based nanogels were synthesized by ionic complexation of CS with 
PEO-b-poly(sodium 2-(acrylamindo)-2-methylpropanesulfonate), followed by an addition of 
genipin. Genipin is an irridoid glucoside extracted from Gardenia, and reacts with primary amine 
 25 
 
groups. The resulting nanogels had a diameter  50 nm in the swollen state by dynamic light 
scattering (DLS) and  20 nm in dry state by transmission electron microscopy (TEM).[134] 
In addition, further modification of polysaccharides is required for ionic gelation. DeX was 
modified with PEG and cystamine to yield PEO-DeX-ss-NH2. The protonated amino groups 
interacted with negatively-charged indocyanine green (ICG), a tricarbocyamine dye, to form 
ICG/DeX nanogels. Since ICG is a FDA-approved near infrared (NIR) fluorescent dye to be used 
in clinics, the resulting nanogels are useful for NIR imaging and photothermal therapy.[135] In 
another report, wood CeL was modified with carboxymethyl groups, yielding negatively charged 
CMC. Wood CeL was also quarternized with ammonium salts, yielding positively charged CeL 
(QCeL). Mixing of the CeL-based polysaccharides in aqueous solutions resulted in the formation 
of ionically crosslinked CeL-based nanogels for protein delivery. Their sizes could be modulated 
by adjusting either CMC and QCeL in the feed, ranging from 150 to 800 nm in diameter.[136]  
2.4. Polysaccharide-based hydrogels 
2.4.1. Physical crosslinking method 
Similar to crosslinked nanogels, several approaches to synthesize physically crosslinked 
supramolecular hydrogels have been explored. Typical approaches include ionic interactions, 
host-guest inclusion complexation, and thermoresponsive sol-gel transition. 
Ionic interaction includes the interaction of ionic polysaccharides with a broad selection of 
ionic crosslinkers.[137] Examples include ALG bearing COOH groups with Ca2+ and Fe3+ ionic 
species[138-141] and HA bearing COOH groups with gelatin,[142] yielding hydrogels. In contrast to 
homogenous hydrogels, a dual-structure hydrogel was also reported. The amino groups of CS 
were modified, and the formed amphiphilic CS self-assembled to form CS-based nanostructures 
dispersed in aqueous ALG solution. By adding Ca2+ crosslinkers through ionic interactions, the 
resulting mixtures turned to hydrogels composed of CS-based nanostructures embedded in ALG-
hydrogels. The dual-structure gels enabled to encapsulate hydrophobic drug in self-assembled 
nanostructured cores. Additionally, the hydrogels exhibit self-healing property in the presence of 
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glycerol.[143] Other examples include HA with cationic PLL[144] and CS with anionic 
azopolymers,[145] yielding multilayer films.  
Host-guest inclusion complexation utilizes CD with a hydrophobic cavity, which is capable of 
inclusion with guest molecules, typically PEG derivatives. Examples include pyrene-terminated 
PEG star polymers,[146] cholesterol-derived linear PEG,[147] PEG-PPG-PEG triblock 
copolymer,[148] and PEG-grafted disulfide-containing poly(amino amine).[149] These CD/polymer 
inclusion complexes could be useful as injectable smart biomaterials for controlled-drug delivery 
applications. 
Temperature-induced sol-gel transition involves the design of thermoresponsive polymers that 
undergo a volume change due to hydrophobic/hydrophilic transition in respond to temperature 
change. This property enables sol-gel transition of the polymers at higher concentrations, 
resulting in the formation of in situ formed hydrogels. This approach involves the modification of 
polysaccharides with thermoresponsive polymers. For example, CS was modified with PEG-
based block copolymers of polyalanine, yielding CS-g-(PA-b-PEG),[150] and poly(L-alanine-co-
L-phenyl alanine), yielding CS-g-(PAF-b-PEG).[151] HA was also grafted with PNIPAM by 
RAFT polymerization, yielding HA-g-PNIPAM.[152] Recently, HA was conjugated with 
dopamine (Figure 2.8); the resulting HA-dopamine reacted with HS-terminated Pluronic F127 
block copolymer to prepare lightly crosslinked HA/Pluronic gel structure based on a click-type 
catechol-thiol addition. The resulting hydrogels exhibit thermoresponsive sol-gel transition at 




Figure 2.8. Synthesis (A) and sol-gel transition (B) of HA-dopamine and SH-terminated Pluronic 
F127. Reproduced with permission.[153] Copyright 2010, Royal Society of Chemistry.  
2.4.2. Chemical crosslinking method 
Compared to physical crosslinking exhibiting poor ability to tune mechanical properties, 
chemical crosslinking possesses several advantages, including facile control of moduli, swelling 
ratio, and porosity of hydrogels by varying crosslinkers and crosslinking densities.  
FRCP has been explored as a robust method to fabricate polysaccharide-based hydrogels. 
Similar to the preparation of microgels/nanogels of polysaccharides, this approach involves the 
modification of polysaccharides with vinyl or (meth)acrylate moieties to polymerizable 
polysaccharides. Typical examples include methacrylated ChS,[154] methacrylated HA,[155] and 
methacrylated CT,[156] as well as xanthan gum functionalized with maleic anhydride[157] and 
acetylated galactoglucomannan functionalized with alkenes.[158] Different from the 
microgels/nanogels, however, these polymerizable polysaccharides are polymerized in aqueous 
solutions, mostly photopolymerized upon UV irradiation, to form highly crosslinked hydrogels 
for tissue engineering.    
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Facile coupling reactions or condensation reactions have also been explored to fabricate 
polysaccharide-based hydrogels in mild conditions. For the click-type thiol-ene reaction, 
polysaccharides are modified with either SH or vinyl groups. As illustrated in Figure 2.9, HA was 
modified with cysteamine to form SH-modified HA. In addition, hyperbranched 
thermoresponsive copolymers labeled with acrylate groups were synthesized by ATRP of 
thermoresponsive OEOMA in the presence of a difunctional methacrylate (DMA). These 
copolymers reacted with SH-HA through Michael addition reaction, yielding thiol-ene 
crosslinked hydrogels in aqueous solutions.[159, 160] Other examples include thiol-ene crosslinking 
reactions of maleimide modified DeX with thiol-modified β-CD[20] and methacrylate-modified 
HA with DTT.[161] In addition to thiol-ene reaction, copper-free alkyne-azido reaction,[162] Schiff 
base reaction,[163-165] and Diels-Alder reaction[166] have been explored.  
Oxidative crosslinking of dopamine-conjugated polysaccharides provides an alternative route 
to synthesis of crosslinked hydrogels. An example includes the preparation of calcium-free ALG 
hydrogels in the presence of NaIO4, an oxidizing agent for catechol-conjugated ALG.[167] 
Another example is rutin-releasing CS-based hydrogels composed of rutin-conjugated CS-PEG-
tyramine crosslinked by enzymatically-catalyzed oxidation of phenol groups.[168] 
 
Figure 2.9. Synthetic scheme for Michael addition reaction of SH-modified HA with 
hyperbranched thermoresponsive copolymers labeled with acrylate groups to yield thiol-ene 
crosslinked hydrogels in aqueous solution. Reproduced with permission.[159] 
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2.5. Polysaccharide-based fibrous materials 
Electrospinning is a powerful method to fabricate polymer substrates into fibrous materials 
with nanoscale diameters. These fibers possess high specific surface areas, controlled 
compositions, and high porosities; thus they have found their application in various biomedical 
fields.[169, 170] Due to the unique features, electrospun polysaccharide-based fibers enable the 
encapsulation of diverse therapeutic cargo; thus the resulting drug-loaded nanofibers have been 
considered as effective drug delivery carriers. Examples include cellulose acetate phthalate fibers 
for semen induced anti-HIV (human immunodeficiency virus) vaginal drug delivery[171] as well 
as a sodium ALG/PEG blend fibers containing ibuprofen for pulsatile drug release[172] and 
ammonium ALG fibers carrying antibiotics and enzymes.[173] Furthermore, the surfaces of 
electrospun polysaccharide nanofibers have been immobilized with proteins[174] or functionalized 
with lysostaphin[175] for wound healing applications. A challenge to electro-spinning of most 
polysaccharides is associated with their poor solubility in organic solvents. The use of room 
temperature ionic liquids offers a solution to overcome these difficulties.[176, 177] 
2.6. Summary and Outlook 
The recent advances in the development of polysaccharide-based biomaterials for bio-related 
applications are summarized. Polysaccharides possess a high content of hydroxyl, amino, and 
carboxylic acid groups. These functional groups have been used for modification of 
polysaccharides; the resulting modified polysaccharides are extensively explored as effective 
building blocks to fabricate self-assembled micelles, crosslinked microgels, nanogels, hydrogels, 
and fibrous materials. Self-assembled micelles were prepared by both “grafting to” and “grafting 
from” methods. To form well-defined micellar aggregates, the hydrophobic/hydrophilic balance 
of modified polysaccharides is a key criteria. It can be achieved by tuning the substitution degree 
of hydrophobic moieties. For grafting to method, click-type reactions such as 1,3-cycloadditon of 
alkynes and azides and thiol-ene addition have been utilized to modify polysaccharides with 
small hydrophobic molecules and polymers. For grafting from method, well-known polymer 
synthesis methods such as ROP and CRP have been utilized. Crosslinked nanomaterials 
(microgels, nanogels, and hydrogels) were fabricated by both chemical and physical crosslinking 
reactions. Chemical crosslinking methods include further click-type, facile coupling reactions, 
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and in situ disulfide crosslinking methods as well as FRCP, while physical crosslinking methods 
include ionic interactions, host-guest inclusion complexation, and thermoresponsive sol-gel 
transition.  
Future development of polysaccharide-based biomaterials, particularly for tumor-targeting 
intracellular drug delivery, requires a high degree of control over properties. One property is the 
controlled/enhanced release of encapsulated therapeutics. Although polysaccharides are 
biodegraded by enzymatic reactions, the enzymatic degradation is intrinsically slow; such slow 
degradation causes slow release of encapsulated therapeutics from polysaccharide-based 
nanocarriers and scaffolds in cellular environments. A promising solution to circumvent the 
challenge is the multiple stimuli-responsive degradation platform. Multi-stimuli responses to 
each stimulus can independently and precisely regulate encapsulated drug release. Another 
property is the narrow size distribution. Although the inverse (mini)emulsion technique has been 
explored to synthesize polysaccharide-based nanogels with relatively narrow size distribution, 
harsh conditions are required for the complete removal of residual oil-soluble surfactants 
remaining in the products. Temperature-driven self-assembly/crosslinking is a promising method 
that should be further explored to nanogels with narrow size distribution. Combined with these 
properties, the applicability of these biomaterials in response to cellular components toward 




Chapter 3  
Development of pH/reduction-responsive CMC-based 
bionanogels 
 
Biopolymer-based nanogels (bionanogels) are a promising platform as polymer-based drug 
delivery systems encapsulating hydrophilic anticancer therapeutics; however, 
enhanced/controlled drug release is highly desired. Herein, we report new dual stimuli-responsive 
bionanogels (ssBNGs) as potential intracellular delivery nanocarriers with multi-controlled and 
enhanced drug release. A facile aqueous crosslinking polymerization of oligo(ethylene oxide)-
containing methacrylate (OEOMA) in the presence of carboxymethyl cellulose (CMC) and a 
disulfide-labeled dimethacrylate allows for the synthesis of ssBNGs crosslinked with disulfide 
linkages of POEOMA-grafted CMC. These ssBNGs exhibit dual response release of 
encapsulated anticancer drugs: reductive cleavage of disulfide crosslinks and acidic pH-response 
of carboxylic acid groups in CMC. Their applicability toward tumor-targeting drug delivery 
applications is demonstrated with confocal laser scanning microscopy for cellular uptake and cell 
viability, as well as a facile bioconjugation with a water-soluble UV-active dye as a model cell-
targeting biomolecule.  
This chapter contains information that was published in RSC Advances. 2014, 4, 229-237 and 




Polymer-based drug delivery systems (PDDS) are a promising platform in biomedical 
applications such as tissue engineering, biomedical implants, bionanotechnology, and drug 
delivery. Drug molecules are either physically encapsulated inside particles or covalently 
attached to polymeric chains, thus enhancing therapeutic efficacy while reducing side effects 
common to small drugs.[178-182] Typical examples of PDDS include drug conjugates 
(prodrugs),[183-185] hydrophobic particulates,[186-188] vesicles,[189] nanocapsules,[190, 191] and self-
assembled micellar aggregates.[192-194] Particularly, nanogels are crosslinked hydrogel particles 
that are confined to nanometer-sized dimensions, which are smaller than micron-sized hydrogel 
particles (i.e. microgels).[195-198] They have the unique properties of hydrogels including high 
water content, biocompatibility, adjustable chemical and mechanical properties. These nanogels 
also possess tunable size, a large surface area for multivalent bioconjugation, and an interior 
network for the incorporation of therapeutics.[199-203] 
Biopolymer-based nanogels (bionanogels) have all the properties of synthetic counterparts 
(i.e. nanogels) as well as all benefits from biopolymers being intrinsically biodegradable, 
abundant in nature, renewable, nontoxic, and relatively cheap.[56, 204-206]  They also possess a high 
content of functional groups including hydroxyl, amino, and carboxylic acid groups. These 
functional groups can be further utilized for bioconjugation with cell targeting agents. In addition 
to bionanogels, the development of biopolymer-based hydrogels,[207-209] capsules,[72, 210] 
nanofibrous membranes,[211] and polyplexes[212] have been explored for various biomedical 
applications. Despite these advances, the controlled/enhanced release from bionanogels remains 
challenging. 
Enhanced and controlled release of encapsulated anticancer therapeutics in targeted cancer 
cells is a highly desired property in constructing effective PDDS, particularly 
nanogels/microgels.[213-215] A promising method is to incorporate stimuli-responsive properties 
into nanogels/microgels. In response to external stimuli, these stimuli-responsive materials either 
undergo volume changes[216, 217] or are degraded by cleavage of dynamic covalent bonds;[114, 116] 
such changes enable the enhanced release of encapsulated cargoes. Typical external triggers 
include temperature,[218, 219] pH,[220-222] light,[223, 224] and salts,[225] as well as enzymatic[226-228] and 
reductive reactions.[229-232] Of our interest, low pH-sensitive systems, while stable at 
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physiological pH, are destabilized in acidic conditions, facilitating the release of encapsulated 
drugs in a controlled manner. Tumor tissue as well as endosomes and lysosomes present slightly 
acidic pH (5.0 - 6.5). Reduction-responsive degradable systems typically employ disulfide-thiol 
chemistry where disulfides are cleaved to the corresponding thiols in response to reductive 
reactions.[233, 234] In biological systems, glutathione (GSH reduced form) exhibit the largely 
different redox potential between intracellular and extracellular compartments; furthermore, GSH 
exists at elevated concentration in cancer cells (> 10 mM).[235, 236] In the design and development 
of smart bionanogels, surprisingly, the stimuli-responsive drug release has not been extensively 
studied yet. Most stimuli-responsive bionanogels were formed through self-assembly of 
amphiphilic biopolymers modified with pendant dynamic linkages.[118, 237-239]    
Several methods utilizing chemical crosslinking have been proposed to synthesize various 
bionanogels in aqueous solution. Typical methods include free radical polymerization (FRP) of 
methacrylate-modified polysaccharides[120, 240] and polycondensation/or polyaddition of 
polysaccharides bearing reactive functional groups.[24, 241-243] A promising method involves 
aqueous FRP of methacrylate monomers in the presence of polysaccharides that allows for the 
synthesis of polymethacrylate-grafted polysaccharides. This method is versatile in that the 
properties of polysaccharides can be tuned with varying polymethacrylates. Examples of grafted 
polymethacrylates include poly(acrylic acids) for pH response,[244] as well as poly(N-isopropyl 
acrylamide)[245] and poly(acrylamide)[125] for temperature  response. However, only few reports 
describe the synthesis of microgels or nanogels utilizing the aqueous FRP in the presence of 
dimethacrylate crosslinkers.[126, 127]  
This paper describes dual-stimuli reduction and low pH-responsive bionanogels crosslinked 
with disulfide linkages (ssBNGs) as intracellular delivery nanocarriers with enhanced release. 
Scheme 3.1 illustrates our approach. Aqueous FRP of oligo(ethylene oxide) (OEO)-containing 
methacrylate (OEOMA) in the presence of carboxymethyl cellulose (CMC) was examined to 
synthesize POEOMA-grafted CMC (POEOMA-g-CMC). Water-soluble POEOMA was targeted 
to be grafted from CMC as the scaffold materials. POEOMA is an analog of poly(ethylene oxide) 
(PEO); PEO is biocompatible material that has been FDA-approved for clinical use, has low 
toxicity, and prevents nonspecific protein adsorption.[246, 247] An introduction of a disulfide-
labeled dimethacrylate (ssDMA) as a crosslinker into aqueous free radical crosslinking 
polymerization (FRCP) yielded ssBNGs based on disulfide-crosslinked POEOMA-g-CMC. 
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These ssBNGs exhibit dual-controlled release of encapsulated anticancer drugs: reductive 
cleavage of disulfide crosslinks and acidic pH-response of carboxylic acid (COOH) groups in 
CMC. Their applicability as intracellular anticancer drug delivery nanocarriers was evaluated 
using confocal laser scanning microscopy (CLSM) for cellular uptake and cell viability 
measurements. Furthermore, their facile bioconjugation with a water-soluble UV-active dye as a 
model cell-targeting biomolecule was demonstrated. 
 
Scheme 3.1. Synthesis by aqueous FRCP, bioconjugation, and dual stimuli-response of 
biopolymer-based ssBNGs crosslinked with disulfide linkages of POEOMA-g-CMC. 
3.2 Experimental   
3.2.1 Instrumentation and analysis 
1H-NMR spectra were recorded using a 500 MHz Varian spectrometer. The D2O singlet at 
4.8 ppm and the CDCl3 singlet at 7.26 ppm were selected as reference standards. Spectral 
features are tabulated in the following order: chemical shift (ppm); multiplicity (s, singlet; d, 
doublet; t, triplet; m, complex multiple); number of protons; position of protons. Conversion was 
determined by 1H-NMR. Molecular weight and molecular weight distribution were determined 
by gel permeation chromatography (GPC). An Agilent GPC was equipped with a 1260 Infinity 
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Isocratic Pump and a refractive index (RI) detector. Two Agilent PLgel mixed-C and mixed-D 
columns were used with DMF containing 0.1 mol% LiBr at 50 °C at a flow rate of 1.0 mL/min. 
Linear poly(methyl methacrylate) (PMMA) standards from Fluka were used for calibration. 
Aliquots of polymer samples were dissolved in DMF/LiBr. The clear solutions were filtered 
using a 0.25 m PTFE filter to remove any DMF-insoluble species. A drop of anisole was added 
as a flow rate marker. UV/Vis spectra were recorded on Agilent Cary 60 UV/Vis spectrometer 
equipped with an external probe. 
3.2.2 FT-IR measurements  
FT-IR spectra of all the samples were taken on a Nicolet 6700 FT-IR spectrometer using 
KBr pellets. All spectra were recorded with 32 scans in resolution of 4 cm-1 at room temperature 
in the range of 500 - 4000 cm-1. Background noises were corrected with pure KBr. For data 
processing, the baselines of all spectra were corrected. To prepare specimens, as-synthesized 
aqueous polymer solutions (15 mL) were precipitated from acetone (300 mL) under stirring for 
12 hrs. The resulting mixtures were centrifuged under the conditions of 6,000 rpm x 10 min x 4 
C. After vacuum filtration, the precipitated polymers were dried in a vacuum oven at 50 C for 1 
day. The dried polymer samples were then mixed with KBr powders to prepare pellets for FT-IR 
measurements. 
3.2.3 Dynamic light scattering (DLS) measurements  
The sizes in hydrodynamic diameters by volume of POEOMA-g CMC polymers and 
ssBNGs in aqueous solution were measured by dynamic light scattering (DLS) at a fixed 
scattering angle of 173° at 20 °C with a Malvern Instruments Nano S ZEN1600 equipped with a 
633-nm He-Ne gas laser. The number average diameter (Dn) =  ∑ࢊ࢏ࢂ࢏%∑ࢂ࢏%  , weight average diameter 
(Dw) =  ∑ࢊ࢏૛ࢂ࢏%∑ࢊ࢏ࢂ࢏% , and polydispersity =  
ࡰ࢝
ࡰ࢔, where di is a diameter of particle i and Vi% is a volume 
faction of particle i. Note that volume faction < 0.5% was not included in the calculation. 
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3.2.4 Transmission electron microscopy (TEM)  
TEM images were taken using a Philips Tecnai 12 TEM, operated at 120 kV and equipped 
with a thermionic LaB6 filament. An AMT V601 DVC camera with point to point resolution of 
0.34 nm and line resolution of 0.2 nm was used to capture images at 2048 by 2048 pixels. To 
prepare specimens, the nanogel dispersions were dropped onto copper TEM grids (400 mesh, 
carbon boated), blotted and then allowed to air dry at room temperature. 
3.2.5 Materials  
Carboxymethylcellulose sodium salts (CMC) with average MW  250 kg/mol and viscosity 
= 400 - 800 cP at 2 wt% in water, oligo(ethylene oxide) methacrylate (OEOMA-OH) with MW = 
526 g/mol and #EO units  10, 3,3-dithiopropionic acid (ssDCOOH, 99%), N,N-dicyclohexyl 
carbodiimide (DCC), N,N-dimethylaminopyridine (DMAP), doxorubicin hydrochloride (DOX, -
NH3+Cl- salt forms, > 98%), glutathione (GSH, reduced form), potassium phosphate monobasic 
(KHP), and KBr (FT-IR grade, ≥ 99%) from Aldrich Canada, 2,2'-azobis[2-(2-imidazolin-2-
yl)propane]dihydrochloride (VA-44) from Wako Chemie, and 8-aminopyrene-1,3,6-trisulfonic 
acid trisodium salt (APTS, MW  = 523.4 g/mol) from Biotium were purchased and used as 
received. Dialysis tubing with MWCO = 12,000 g/mol with a diameter = 25 mm was purchased 
from Spectrum Laboratories. Oligo(ethylene oxide) monomethyl ether methacrylate (OEOMA) 
with MW = 475 g/mol and #EO units  9 was purchased from Aldrich Canada and purified by 
passing through a column filled with basic alumina to remove inhibitors before used.  
Dithiopropionyl poly(ethylene glycol) dimethacrylate (ssDMA) was synthesized as described 
in our previous report.[248] Briefly, ssDCOOH (4.6 g, 20 mmol) dissolved in THF (60 mL) 
reacted with OEOMA-OH (20 g, 38 mmol) in the presence of DCC (7.8 g, 38 mmol) and a 
catalytic amount of DMAP in dichloromethane (DCM, 120 mL). The product was purified by 
vacuum filtration and solvent evaporation. 1H-NMR (CDCl3, 7.26 ppm): 1.9 (s, 6H, -CH3), 2.7 (t, 
4H, -C(O)-CH2-CH2-SS-), 2.9 (t, 4H, -C(O)-CH2-CH2-SS-), 3.5-3.8 (m, EO protons), 4.0-4.3 (m, 
8H, -C(O)O-CH2- and –CH2-O(O)C-), 5.6 (s, 2H, CH=), and 6.1 (s, 2H, CH=). 
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3.2.6 Synthesis of ssBNGs crosslinked with disulfides 
OEOMA (50 mg, 0.11 mmol), CMC (50 mg), and an aqueous stock solution of ssDMA (0.5 
mL, 2 mg/mL, 0.82 µmol) were dissolved in water (15 mL) in 25mL of Schlenk flask. The 
resulting clear mixture was purged with nitrogen for 30 min under magnetic stirring and then 
heated to 40 C in a water bath for 10 min. A nitrogen-prepurged aqueous stock solution of VA-
44 (0.3 mL, 10 mg/mL) was added using a syringe to initiate the polymerization. The 
polymerization stopped at 5 hrs by cooling down to room temperature. The resulting ssBNGs 
were purified by intensive dialysis for 24 hrs against water for DLS and conjugation experiments 
as well as against PBS for cell culture experiments.  
3.2.7 Loading of DOX 
 DOX (2.3 mg, 5 wt% of ssBNGs solids) was dissolved in aqueous ssBNGs solution (5.9 
mg/mL, 8 mL). The resulting mixture was stirred at room temperature for 24 hrs and dialyzed 
against water (1 L). Outer water was changed every 12 hrs to remove free DOX for 36 hrs, 
yielding aqueous DOX-loaded ssBNGs solution at 4.3 mg/mL. Their UV/Vis spectra were 
recorded and the loading level of DOX was calculated by the weight ratio of loaded DOX to 
dried polymers.  
3.2.8 Dual-responsive release of DOX using UV/Vis spectroscopy 
For acidic pH-responsive release, aliquots of aqueous DOX-loaded ssBNGs solution (2 mL) 
were placed in a dialysis tubing and immersed in aqueous KHP buffer solutions at different pH 
values (50 mL). The absorbance of DOX in outer water was recorded at an interval of 5 min 
using a UV/Vis spectrometer equipped with an external probe at ex = 497 nm. For quantitative 
analysis, the solution in the tubing was combined with outer water and the UV/Vis spectrum of 
the resulting mixture was recorded. For reduction-responsive release of DOX, the similar 
procedure was applied except for the use of outer aqueous buffer solution with and without 5 mM 
GSH at pH = 7.  
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3.2.9 Cell culture  
HeLa cancer cells were cultured in DMEM (Dulbecco’s modified Eagle’s medium) 
containing 10% FBS (fetal bovine serum) and 1% antibiotics (50 units/mL penicillin and 50 
units/mL streptomycin) at 37 C in a humidified atmosphere containing 5% CO2.  
3.2.10 Confocal laser scanning microscopy (CLSM)  
Cells plated at 2×105 cells/well into a 6-well plate were incubated with DOX-loaded ssBNGs 
(200 L for DOX = 21 g) and free DOX (21 g) as a control at 37 C for 2 and 8 hrs. After 
culture medium was removed, cells were washed with PBS three times. After the removal of 
supernatants, the cells were fixed with cold methanol (-20 C) for 20 min at 4 C. The slides were 
rinsed with tris-buffered saline Tween-20 (TBST) three times. Cells were stained with 2-(4-
amidinophenl)-6-indolecarbamidine (DAPI) for 5 min. The fluorescence images were obtained 
using a LSM 510 Meta/Axiovert 200 (Carl Zeiss, Jena, Germany).  
3.2.11 Cell viability using MTT assay 
Cells were plated at 5 x 105 cells/well into a 96-well plate and incubated for 24 hrs in 
DMEM (100 µL) containing 10% FBS for the following experiments. They were then incubated 
with various concentrations of empty and DOX-loaded ssBNGs for 48 hrs. Blank controls (cells 
only) were run simultaneously. Cell viability was measured using CellTiter 96 Non-Radioactive 
Cell Proliferation Assay kit (MTT, Promega) according to manufacturer’s instruction. Briefly, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solutions (15 µL) was added 
into each well. After 4 hrs incubation, the medium containing unreacted MTT was carefully 
removed. DMSO (100 L) was added into each well in order to dissolve the formed formazan 
blue crystals, and then the absorbance at  = 570 nm was recorded using Powerwave HT 
Microplate Reader (Bio-Tek). Each concentration was 12-replicated. Cell viability was calculated 
as the percent ratio of absorbance of mixtures with nanogels to control (cells only). 
3.2.12 Conjugation of ssBNGs with APTS  
An aqueous APTS stock solution (0.83 mL, 5 mg/mL) was mixed with aqueous ssBNGs 
solution (1 mL, 6 mg/mL) in the presence of an aqueous stock solution of EDC (1.1 mL, 10 
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mg/mL) under stirring at room temperature for 1 day. The mixture was then dialyzed against 
water for 3 days to completely remove unreacted APTS dyes, yielding aqueous APTS-conjugated 
ssBNGs solution at 1.1 mg/mL.  
3.3 Results and Discussion   
3.3.1 Preparation of ssBNGs based on crosslinked POEOMA-g-CMC 
Our approach to synthesize dual stimuli-responsive ssBNGs involves the aqueous free 
radical polymerization (FRP) of OEOMA in the presence of CMC and a disulfide-labeled 
dimethacrylate (ssDMA). The synthesis of ssDMA using a facile carbodiimide coupling reaction 
is reported.[248] A water-soluble VA-44 azo-type free-radical initiator was selected because of its 
short half-life at lower temperature (1/2 = 10 hrs at 44 C). For FRP of OEOMA initiated with 
VA-44, conversion reached > 80% within 2 hrs at 40 C (Table A.1). Due to the high molecular 
weight of CMC, the viscosity of its aqueous solution strongly relies on the concentration of 
CMC. It was found that 1 wt% aqueous CMC solution is suitable for FRP. For the concentration 
of OEOMA, a series of aqueous FRP of different amounts of OEOMA in the presence of 1 wt% 
CMC without ssDMA was carried out. The results show that the average diameter of the resulting 
particles based on POEOMA-grafted CMC increased with an increasing amount of OEOMA 
(Figure A.1 and Table A.2). Such increase is attributed to an increase in probability of intra- or 
inter-particle coupling reaction. At 3.3 mg/mL concentration, the resulting particles based on 
POEOMA-grafted CMC had an average diameter ≈ 14 nm with a monomodal distribution. 
A 1.5 mol% of ssDMA was introduced into aqueous FRP of OEOMA in the presence of CMC 
= 1wt% and VA-44 = 2 wt% of OEOMA at 3.3 mg/mL. After 5 hrs, monomer conversion was 
determined by 1H-NMR to be > 80%. The resulting ssBNGs were then purified by intensive 
dialysis to remove unreacted monomers. DLS results suggest the presence of two populations. 
The main population (> 90% volume) is smaller-sized aggregates with Dn  24 nm, which is 
larger than that ( 14 nm) prepared in the absence of ssDMA. In addition, a smaller population (< 
10% volume) is larger-sized aggregates with the diameter > 0.8 m (Figure 3.1a). TEM images 
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indicate near-spherical shapes of ssBNGs with average diameter = 19.5 ± 4.1 nm, which is 
similar to that determined by DLS (Figure 3.1b).  
 
 




Aqueous FRP process allows for the synthesis of polymethacrylates grafted from 
polysaccharide-based biopolymers.[249, 250] However, this process also forms undesired 
polymethacrylate homopolymers; such as polyacrylamide,[125] poly(methyl methacrylate),[251] and 
poly(3-dimethyl-(methacryloyloxyethyl) ammonium propane sulfonate).[252] They were removed 
by intensive extraction with appropriate solvents.  
In our control experiment without ssDMA, the results from our solubility tests suggest that 
acetone and a mixture of ethanol and acetic acid could be good solvents to POEOMA 
homopolymers, but poor solvents to CMC (Table A.3). Accordingly, the POEOMA-g-CMC 
prepared without ssDMA (FRP-C1) was precipitated from acetone to remove undesired 
POEOMA homopolymers and unreacted OEOMA. As seen in Figure A.2, the FT-IR spectrum of 
the POEOMA-g-CMC exhibits two characteristic bands at 1605 cm-1 corresponding to 
carboxylate (C(=O)O-) anion absorption of CMC and at 1730 cm-1 corresponding to ester C=O 
vibrational absorption of POEOMA, suggesting the formation of POEOMA-g-CMC. Similarly, 
ssBNGs prepared in the presence of ssDMA were precipitated from acetone. Note that the 
undesired products of POEOMA homopolymers crosslinked in the presence of ssDMA could be 
dissolved in acetone as microgel particles and thus they will be removed. As seen in Figure 3.2, 
the FR-IR spectrum of the precipitated ssBNGs exhibits the two typical vibrational absorptions at 




Figure 3.2. FT-IR spectrum of ssBNGs, compared with that of POEOMA-g-CMC. 
3.3.2 Loading of anticancer drugs  
To preliminarily evaluate ssBNGs as a platform with enhanced release for tumor-targeting 
drug delivery, doxorubicin (DOX), a DNA-interacting anticancer drug used in chemotherapy, 
was encapsulated in ssBNGs. An aqueous DOX stock solution was mixed with ssBNGs in water 
(pH = 6.5). Free (not encapsulated) DOX was removed by intensive dialysis for 36 hrs. The 
removal of free DOX was monitored by measuring the absorbance of DOX at 497 nm in outer 
water (Figure A.3). In this way, DOX-loaded ssBNGs in aqueous solution at 4.3 mg/mL was 
prepared. The loading level of DOX for DOX-loaded ssBNGs was determined using UV/Vis 
spectroscopy. UV/Vis spectrum of DOX-loaded ssBNGs is similar to that of free DOX, 
suggesting no signification change in the structure of DOX encapsulated in ssBNGs (Figure A.4). 
The Beer-Lambert equation with the absorbance and the extinction coefficient of 10,000 M-1 cm-1 
at  = 497 nm[253] was used to determine the loading level of DOX to be 3.4 ± 0.1% and its 
loading efficiency to be 68.6 ± 3.1% at the weight ratio of DOX/ssBNGs = 1/20. 













1730 cm-1 1605 cm-1
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3.3.3 Dual responsive release of encapsulated anticancer drugs  
The release of DOX from DOX-loaded ssBNGs in response to both acidic pH and thiol 
reducing agents was investigated. To examine acidic pH-responsive release, aliquots of DOX-
loaded ssBNGs in dialysis tubing were placed in aqueous KHP buffer solutions at different pH 
values of 3, 5.5, and 7. Figure 3.3 shows the significant dependence of DOX release upon acidic 
pH values. Figure 3.3b - e show the digital photos of outer water and the corresponding dialysis 
tubing before and after release. The release of DOX was enhanced in the order of pH 3 > pH 5.5 
> pH 7. This enhancement is attributed to the extent of interactions between COOH groups of 
CMC in ssBNGs and amine (NH2) groups of DOX. Because of pKa of DOX = 8.3, most amine 
groups of DOX exist as protonated forms (NH3+ forms) in the range of pH values examined here. 
However, COOH groups exist as their neutral forms (COOH forms) at below pKa = 4.8 or their 
deprotonated forms (COO- forms) at above pKa. It is obvious that protonated NH3+ forms of 
DOX have weaker interactions with neutral COOH forms of CMC than deprotonated COO- 
forms. As a consequence, the release of DOX was faster at pH = 3 than pH = 7.  
Next, reductively responsive release of DOX was examined at pH = 7 in a way that aliquots 
of DOX-loaded ssBNGs in dialysis tubing was placed in aqueous buffer solution with and 
without (control) 5 mM GSH. As seen in Figure 3.4, the release of DOX was relatively faster in 
the presence of 5 mM GSH, compared to no GSH. Such slight enhancement is the result of GSH-
induced degradation of ssBNGs by cleavage of disulfides. These results suggest that acidic pH-
response is more significant than thiol-response in enhancing the release of DOX from ssBNGs 




Figure 3.3. Release of DOX from DOX-loaded ssBNGs in aqueous buffer solutions at different 
pH of 3, 5.5, and 7 (a), and digital photos of outer water (upper) and the corresponding dialysis 





Figure 3.4. Release of DOX from DOX-loaded ssBNGs in aqueous buffer solutions at pH = 7 
with and without 5 mM GSH. 
3.3.4 Intracellular release as anticancer drug delivery nanocarriers  
Intracellular trafficking of DOX from DOX-loaded ssBNGs after cellular uptake was 
examined using CLSM. Figure 3.5 shows CLSM images of HeLa cells incubated with and 
without DOX-loaded ssBNGs for 2 and 8 hrs. For comparison, HeLa cells were also incubated 
with free DOX. HeLa nuclei were stained with DAPI to provide enhanced contrast and clarity. 
Compared to free DOX as a control (Figure 3.5d and e), the images from DOX fluorescence 
suggest that DOX-loaded ssBNGs were internalized and DOX was released to reach cell nuclei 
within 2 hrs (Figure 3.5b). When the incubation time increased to 8 hrs, the DOX fluorescence 
became brighter, suggesting more DOX reached cell nuclei (Figure 3.5c). 
A MTT colorimetric assay was used to evaluate cytotoxicity of HeLa cells in the presence of 
empty and DOX-loaded ssBNGs (Figure 3.6). The empty crosslinked ssBNGs exhibited > 90% 
HeLa cell viability at concentrations up to 200 μg/mL, suggesting non-toxicity of ssBNGs to 
cells. In the presence of DOX-loaded ssBNGs at 200 μg/mL ( 3.5 μg/mL DOX), however, the 
viability decreased to below 20%, suggesting inhibition of cell proliferation in the presence of 
DOX. The results from cell viability and CLSM measurements suggest that DOX release from 

















DOX-loaded ssBNGs, possibly triggered by intracellular GSH and acidic pH inside cancer cells, 
enhanced the inhibition of the cellular proliferation.  
 
Figure 3.5. CLSM images of HeLa cells incubated with empty ssBNGs for 8 hrs (a), DOX-






Figure 3.6. Viability of HeLa cells incubated with empty and DOX-loaded ssBNGs for 48 hrs 
determined by MTT assay. Data are presented as the average ± standard deviation (n = 12) 
3.3.5 Bioconjugation for active targeting  
Active targeting to specific cells through bioconjugation of delivery vehicles with cell 
targeting agents is a desired property for PDDS. Specific targeting could reduce the serious side 
effects of drugs as well as enhance the drug efficiency.[254, 255]  Polysaccharides including CMC 
possess a high content of functional groups including hydroxyl and carboxylic acid groups. These 
functional groups can be further utilized for bioconjugation with cell targeting agents. To assess 
an applicability of ssBNGs based on crosslinked POEOMA-g-CMC toward targeted delivery, the 
conjugation of COOH groups in CMC with a water-soluble APTS dye was examined in aqueous 
solution through an EDC-coupling reaction.  
A known amount of ssBNGs was mixed with free APTS in the presence of EDC at room 
temperature for 1 day. The mole ratio of [COOH]/[APTS]/[EDC] = 1/0.5/4.5. The mole of 
COOH was calculated from the carboxylate content = 70% (from supplier’s catalog). Unreacted 
APTS dyes were removed by intensive dialysis against water. Figure 3.7 shows the UV/Vis 
spectra of APTS-conjugated ssBNGs and free APTS in aqueous solutions at pH = 7. The 





















APTS-bound ssBNGs. As a control experiment, the pH-dependence of UV absorption of free 
APTS was examined in aqueous solutions at a broad range of pH from 2 to 10 (Figure A.5). At 
above pH = 2, its UV/Vis spectra retained similar with its maximum absorption at  = 424 nm, 
while it was blue-shift at below pH = 2. Note that the UV/Vis spectrum of APTS-conjugated 
ssBNGs was recorded at pH = 7. Consequently, the blue-shift after conjugation is attributed to 
the formation of new amide linkages, suggesting the successful conjugation of ssBNGs with 
APTS to form APTS-conjugated ssBNGs (see Scheme 3.1).  
For quantitative analysis, the extinction coefficient of APTS at max = 424 nm was 
determined to be ε = 21,700 M-1 cm-1 in water (pH = 6.5) (Figure A.6). UV/Vis spectra of the 
mixture consisting of ssBNGs, APTS, and EDC before and after the occurrence of EDC coupling 
reaction are compared in Figure 3.7. Using the extinction coefficient and the difference of the 
absorbance at  = 424 nm, the conjugation efficiency of COOH groups in ssBNGs with APTS 
was estimated to be 15% under these conditions. 
 
 
Figure 3.7. UV/Vis spectra and digital photos (insect) of aqueous solution of APTS-conjugated 





Polysaccharide-based ssBNGs crosslinked with disulfide linkages of POEOMA-g-CMC 
exhibiting dual-stimuli reduction and acidic pH responses were synthesized by a facile aqueous 
free radical crosslinking polymerization of OEOMA in the presence of CMC and ssDMA at 
ambient temperature. In the absence of crosslinkers, the initiator concentration, temperature, and 
OEOMA concentrations were revealed to be important parameters that significantly influence the 
polymerization kinetics and grafting of POEOMA from CMC chains. Introduction of ssDMA 
yielded dual stimuli-responsive ssBNGs with diameter ≈ 24 nm, confirmed by DLS and TEM. 
Toward intracellular anticancer drug delivery, DOX was encapsulated at loading level = 3.4%. 
The results from UV absorbance measurements suggest the enhanced release of DOX in response 
to acidic pH as well as in the presence of GSH; interestingly, acidic pH-response is more 
significant than GSH-response in enhancing DOX release. Furthermore, the intracellular release 
of anticancer drugs after internalization into HeLa cancer cells is confirmed with the results from 
CLSM and MTT viability assay. These results, combined with the ability to facile bioconjugation 
with a cell-targeting model biomolecule in aqueous solution, suggest that the ssBNGs are a 




Chapter 4  





Polysaccharide-based crosslinked nanogels (bionanogels) exhibiting multiple stimuli-
responsive release of encapsulated therapeutics hold a great potential as tumor-targeting 
intracellular drug delivery nanocarriers. Herein, we report the synthesis of monodisperse dual 
temperature/acidic pH-responsive bionanogels (DuR-BNGs) by aqueous crosslinking 
polymerization through temperature-induced self-association method. The DuR-BNGs have 
prolonged colloidal stability and negligible non-specific interactions with proteins. In response to 
acidic pH and higher temperature (above LSCT), they exhibit synergically rapid release of 
anticancer drugs as a consequence of both acidic pH-sensitivity of CMC and temperature-induced 
volume changes of grafted thermoresponsive copolymers. In vitro cell culture results suggest that 
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new DuR-BNG is a promising candidate with enhanced colloidal stability and dual stimuli-
responsive drug release for chemotherapy. 
This chapter contains information that was submitted in Colloids and Surfaces B: 






In recent decades polymer based drug delivery systems (PDDS) have been a choice of 
materials that can overcome limitations in conventional chemotherapy: undesired side effects and 
low drug efficiency common to small drugs.[178-182] Therapeutic molecules are commonly 
incorporated into PDDS through physical encapsulation or covalent attachment.[256-258] These 
drug-loaded PDDS are designed to retain prolonged blood circulation. They are then specially 
extravasated into tumor tissues through enhanced permeability and retention (EPR) effect. This 
passive targeting enables to improve bioavailability and biodistribution of small drugs in tumor 
tissues.[3-5] Typical examples of PDDS include self-assembled block copolymer micelles[108, 193, 
194, 259, 260] and nanocapsules.[190, 191] However, due to their formation driven by physical 
association of polymeric chains, they often suffer from the premature release of encapsulated 
drugs during blood circulation upon the dilution in blood ( 4 L).[28] In contrast, well-defined 
nanogels possess inherent colloidal stability due to being crosslinked.[195-198] Promisingly, 
polysaccharide-based nanogels (bionanogels, BNGs) offer a number of unique features. 
Polysaccharides are biocompatible, intrinsically biodegradable, and easily obtained from a 
variety of natural resources. They possess a plenty of functional groups such as -OH, -COOH and 
-NH2 groups, which can facilitate further modification of BNGs, particularly their bioconjugation 
with cell-targeting molecules.[56, 199-206] 
Toward successful tumor-targeting applications of BNGs, however, a critical challenge to be 
addressed is the slow and uncontrolled release of encapsulated drugs from BNGs.[10] The rapid 
release of cargoes is highly desired for cancer treatment.[215] One promising approach is to design 
smart (or stimuli-responsive) BNGs that undergo either volum change or chemical degradation of 
dynamic covalent linkages in response to external stimuli. This stimuli-responsive platform leads 
to rapid release of encapsulated drugs. While most smart BNGs have been designed to exhibit 
single stimulus-response such as temperature,[218, 219] pH,[220-222] salts,[225] enzymatic[226-228] and 
reductive reactions,[229-232, 261] dual or multiple stimuli-responsive BNGs exhibit more desirable 
drug release kinetics.[122] However, the exploration to synthesize dual responsive BNGs is in 




Another challenge involves the facile synthesis and purification of monomodal BNGs. 
Inverse (mini)emulsion method could yield nanometer-sized BNGs; however, the method 
requires the removal of oil-soluble surfactants to purify BNGs after polymerization.[213, 240] In 
contrast, aqueous polymerization is a convenient method that proceeds with no aid of surfactants. 
The method allows for the synthesis of polysaccharide-grafted polymethacrylates and crosslinked 
BNGs whose properties can be tuned with varying grafted polymethacrylates.[125, 244] Although 
this method does not require tedious purification steps for the removal of surfactants, it yields 
multimodal BNGs with broad size distributions due to undesired inter-chain couplings.[33] 
Monomodal size distribution of BNGs is highly desired for prolonged blood circulation and 
cellular uptake to cancer cells through endocytosis. 
Herein, we report new dual temperature/acidic pH-responsive BNGs (denoted DuR-BNGs) 
with narrow size distribution exhibiting enhanced release and excellent colloidal stabiltiy for 
cancer therapy. As illustated in Scheme 4.1, well-defined monodisperse DuR-BNGs were 
synthesized by aqueous crosslinking polymerization via temperature-driven self-association 
method in aquous solution. Biocompabile carboxymethyl cellulose as a promising polysaccharide 
contains pendant COOH groups that promote the release of encapsulated anticancer drugs in 
acidic tumor tissues, such as pH = 6.5 in extracellular enviroments and 5.0 - 6.5 in endosomes 
and lysosomes inside cancer cells. Grafted thermoresponsive oligo(ethylene oxide)-based 
copolymers are designed to be sensitive to temperatures close to body temperature, leading to 
thermoresponsive enhanced drug release. Further, both stimuli present at higher temperature in 
acidic pH promoted synergic release of encapsulated drugs from the DuR-BNGs. Their versatile 
applicability toward intracellular anticancer drug delivery was further evaluated with the results 







Scheme 4.1. Illustrations of synthesis of dual temperature/acidic pH-responsive DuR-BNGs via 
temperature-driven self-association method and their stimuli-responsive DOX release.  
4.2 Experimental   
4.2.1 Materials  
Carboxymethylcellulose sodium salts (CMC) (MW  250 kg/mol and viscosity = 400 -
800 cP at 2 wt% in water, provided by supplier), doxorubicin hydrochloride (DOX, NH3+Cl- salt 
form, > 98%), potassium hydrogen phthalate (KHP), and KBr (FT-IR grade, ≥ 99%) from 
Aldrich; bovine serum albumin (BSA, > 95%) from MP biomedicals; as well as 2,2'-azobis[2-(2-
imidazolin-2-yl)propane]dihydrochloride (VA-44) from Wako Chemie were purchased and used 
as received without purification. Dialysis tubing with MWCO = 12,000 g/mol were purchased 
from Spectrum Laboratories. Oligo(ethylene oxide) monomethyl ether methacrylate (OEOMA) 
with MW = 300 g/mol and #EO units  5.5, di(ethylene oxide) methyl ether methacrylate 
(MEO2MA), and oligo(ethylene oxide) methyl ether dimethacrylate (OEODMA) was purchased 
from Aldrich Canada and purified by passing through a column filled with basic alumina to 
remove inhibitors before used.  
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4.2.2 Aqueous polymerization to synthesize CMC-g-P(MEO2MA-co-OEOMA) 
A series of aqueous polymerization was carried out in water containing CMC (3.3 mg/mL), a 
mixture of MEO2MA and OEOMA (3.3 mg/mL), and VA-44 (0.23 mg/mL) at 40 C. The 
amount of MEO2MA in the monomer mixtures was varied from 0 to 75 mol%. As a typical 
example for the synthesis of CMC-g-P6 (see Table S1), CMC (50 mg, 0.2 mol), MEO2MA (32 
mg, 0.17 mmol), and OEOMA (17 mg, 0.057 mmol) were dissolved in water (15 mL) in a 25 mL 
Schlenk flask. The resulting clear solution was purged with nitrogen for 30 min, and immersed 
into a pre-heated oil bath at 40 C. A nitrogen pre-purged aqueous stock solution of VA-44 (0.35 
mL, 10 mg/mL, 10.8 mol) was added to initiate polymerization. Polymerization was stopped 
after 5 hrs by cooling to room temperature. Monomer conversion was determined by 1H-NMR. 
The resulting grafted polymers were purified by an intensive dialysis against water for 24 hrs to 
remove unreacted monomers and initiating species.  
 4.2.3 Synthesis of DuR-BNGs by temperature-driven self-association assisted method 
CMC (50 mg, 0.2 mol), MEO2MA (32 mg, 170 mol), OEOMA (17 mg, 57 mol), and an 
aqueous stock solution of OEODMA (0.25 mL, 20 mg/mL, 9.1 µmol) were dissolved in water 
(15 mL) in 25mL of Schlenk flask. The resulting clear mixture was purged with nitrogen for 30 
min under magnetic stirring and then heated to 40 C in a water bath for 10 min. A nitrogen-
prepurged aqueous stock solution of VA-44 (0.35 mL, 10 mg/mL) was added using a syringe to 
initiate the polymerization. The polymerization was stopped after 14 hrs by cooling down to 
room temperature. Similarly, the resulting DuR-BNGs were purified by an intensive dialysis 
against water for 24 hrs.  
4.2.4 Instrumentation and analysis 
1H-NMR spectra were recorded using a 500 MHz Varian spectrometer. The D2O doublet at 
4.8 ppm was selected as the reference standard. FT-IR spectra were recorded on Nicolet 6700 FT-
IR spectrometer using KBr pellets. All spectra were recorded with 32 scans in resolution of  
4 cm-1 at room temperature in the range of 500 - 4000 cm-1. Background noises were corrected 
with pure KBr. For FT-IR measurements, the purified, dried BNGs were mixed with KBr 
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powders to prepare pellets. UV/Vis spectra were recorded on Agilent Cary 60 UV/Vis 
spectrometer equipped with an external probe. 
 4.2.5 Size and morphology analysis  
The sizes in hydrodynamic diameters by volume of grafted copolymers and DuR-BNGs in 
aqueous solution were measured by dynamic light scattering (DLS) at a fixed scattering angle of 
175° at 25 °C with a Malvern Instruments Nano S ZEN1600 equipped with a 633 nm He-Ne gas 
laser. Transmission electron microscopy (TEM) images were taken using a Philips Tecnai 12 
TEM, operated at 120 kV and equipped with a thermionic LaB6 filament. An AMT V601 DVC 
camera with point to point resolution of 0.34 nm and line resolution of 0.2 nm was used to 
capture images at 2048 by 2048 pixels. To prepare specimens, the DuR-BNG dispersions were 
dropped onto copper TEM grids (400 mesh, carbon boated), blotted and then allowed to air dry at 
room temperature. 
4.2.6 Determination of LCST using DLS  
Light scattering (LS) intensity (count rates) of aqueous solution of CMC-g-P(MEO2MA-co-
OEOMA) and DuR-BNGs at 4.6 mg/mL was measured in quartz cuvette, which were sealed with 
a Teflon stopper. The change in light scattering intensity with temperature was then recorded 
from 20 to 90 °C at increments of 1 °C. The LCST was determined from the onset of increase in 
LS intensity. 
4.2.7 Colloidal stability 
An aliquot of DuR-BNG dispersion (1 mL) was mixed with KHP buffer (pH = 5.5) to adjust 
pH to be 5.5 at 4.3 mg/mL. DLS was used to follow their sizes over time, along with DuR-BNG 
dispersion at pH = 7.0. 
4.2.8 Non-specific BSA absorption of DuR-BNGs 
Aliquots of DuR-BNG dispersion (0.3 mL) was mixed with two different volumes (0.8 and 
1.1 mL) of aqueous BSA solution (80 mg/mL) in PBS. The final volume of the mixtures was 
adjusted to be 2 mL with extra PBS. The resulting mixtures were then incubated at 4 ºC for 3 
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days. DLS was used to follow their sizes. Aliquots of the mixtures (DuR-BNGs + BSA) were 
then subjected to centrifugation (13,000 rpm x 30 min) to precipitate the formed DuR-BNG/BSA 
aggregates. Non-specific interaction of DuR-BNGs with BSA was measured using bicinchoninic 
acid (BCA) assay (Pierce® BCA Assay Kit) according to manufacturer’s instruction. Briefly, 
aliquots of the supernatants (25 µL) were transferred into a 96-well plate and mixed with BCA 
reagent (200 µL). Blank controls (BSA only) were run simultaneously. The mixtures were then 
incubated at 37 °C for 30 min. Their absorbance was measured at   = 562 nm using a 
Powerwave HT Microplate Reader (Bio-Tek). The percentage of free BSA was calculated as the 
wt ratio of BSA in the supernatants of the mixtures containing DuR-BNGs to that in control (with 
no DuR-BNGs).  
A calibration curve was constructed as follows; a series of BSA solutions at various 
concentrations ranging 0 - 2000 μg/mL was prepared by diluting standard BSA solution (2 
mg/mL, provided by the manufacture) with different amounts of PBS. The resulting solutions (25 
µL) were transferred into a 96-well plate, and mixed with BCA reagent (200 µL). After the 
mixtures were then incubated at 37 °C for 30 min, their absorbance was measured at   = 562 nm. 
4.2.9 DOX Loading 
DOX-loaded DuR-BNGs were prepared by mixing an aqueous stock solution of DOX (1.3 
mg/mL, 1 mL, 5 wt% of DuR-BNGs solids) with aqueous purified DuR-BNGs (6.1 mg/mL, 4 
mL). After being incubated for 24 hrs at 37 C, the resulting mixture was dialyzed against water 
(1 L) to remove free DOX for 48 hr. Outer water was changed every 12 hrs, yielding aqueous 
DOX-loaded DuR-BNG solution at 4.1 mg/mL. UV/Vis spectra were recorded to determine 
loading level of DOX by the weight ratio of loaded DOX to dried DuR-BNGs.  
4.2.10 Dual stimuli-responsive release of DOX using UV/Vis spectroscopy 
For acidic pH-responsive release, aliquots of aqueous DOX-loaded DuR-BNG solution (2 
mL) were placed in a dialysis tubing and immersed in aqueous KHP buffer solutions at different 
pH values (50 mL). For thermoresponsive release of DOX, the similar procedure was applied. 
Experiments were performed at 25, 37, and 42 °C respectively (pH = 7). The absorbance of DOX 
in outer water was recorded at 3 min intervals of using a UV/Vis spectrometer equipped with an 
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external probe at ex = 497 nm. For quantitative analysis, solution in the tubing was combined 
with outer water and the UV/Vis spectrum of the resulting mixture was recorded. 
4.2.11 Cell culture 
HeLa cancer cells were cultured in DMEM (Dulbecco’s modified Eagle’s medium) 
containing 10% FBS (fetal bovine serum) and 1% antibiotics (50 units/mL penicillin and 50 
units/mL streptomycin) at 37 C in a humidified atmosphere containing 5% CO2.  
4.2.12 Cell viability using MTT assay  
Cells were plated at 5 x 105 cells/well into a 96-well plate and incubated for 24 hrs in 
DMEM (100 µL) containing 10% FBS for the following experiments. They were then incubated 
with various concentrations of empty and DOX-loaded DuR-BNGs for 48 hrs. Blank controls 
(cells only) were run simultaneously. Cell viability was measured using CellTiter 96 Non-
Radioactive Cell Proliferation Assay kit (MTT, Promega) according to manufacturer’s 
instruction. Briefly, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
solutions (15 µL) was added into each well. After 4 h incubation, the medium containing 
unreacted MTT was carefully removed. DMSO (100 L) was added into each well in order to 
dissolve the formed formazan blue crystals, and then the absorbance at  = 570 nm was recorded 
using Powerwave HT Microplate Reader (Bio-Tek). Each concentration was 12-replicated. Cell 
viability was calculated as the percent ratio of absorbance of mixtures with nanogels to control 
(cells only). 
4.2.13 Confocal laser scanning microscopy (CLSM) 
Cells plated at 2×105 cells/well into a 6-well plate were incubated with DOX-loaded DuR-
BNGs (80μL, DOX = 1 μg/mL), free DOX (10μL, DOX = 1 μg/mL) and pure DuR-BNGs (60μL, 
DuR-BNGs = 45μg/mL) as a control at 37 °C for 5h. After culture medium was removed, cells 
were washed with PBS thee times. After the removal of supernatants, the cells were fixed with 
cold methanol (-20 C) for 20 min at 4 C. The slides were rinsed with tris-buffered saline 
Tween-20 (TBST) thee times. Cells were stained with 2-(4-amidinophenl)-6-indolecarbamidine 
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(DAPI) for 5 min. The fluorescence images were obtained using a LSM 510 Meta/Axiovert 200 
(Carl Zeiss, Jena, Germany).  
4.2.14 Flow cytometry 
HeLa cells were plated at 5 × 105 cells/well into a six-well plate and incubated in DMEM (2 
mL) at 37 °C. After 24 h, cells were treated with DOX-loaded DuR-BNGs (80μL, DOX = 1 
μg/mL), free DOX (10μL, DOX = 1 μg/mL) and pure DuR-BNGs (60μL, DuR-BNGs = 
45μg/mL) as a control at 37 °C for 4h. After the culture medium was removed, the cells were 
washed with PBS solution and treated with trypsin. The cells were suspended in DMEM (500 
μL) for flow cytometry measurements. Data analysis was performed by means of a BD 
FACSCANTO II flow cytometer and BD FACSDiva software. 
4.3 Results and Discussion   
4.3.1 Synthesis of DuR-BNGs  
The synthesis of dual temperature and acidic pH-responsive CMC-grafted bionanogels 
(DuR-BNGs) was accomplished by aqueous crosslinking polymerization assisted via 
temperature-driven self-association method (see Scheme 4.1). OEOMA (MW = 300 g/mol, #EO 
= 5.5) and MEO2MA (MW = 188 g/mol, #EO = 2) were selected as biocompatible 
thermoresponsive monomers to demonstrate the feasibility of our system. All polymerizations 
were initiated with a water soluble azo-initiator (VA-44) at 40 ºC in the presence of CMC.  
To study thermal properties of uncrosslinked CMC-grafted thermoresponsive copolymers, 
aqueous polymerization of a mixture of OEOMA and MEO2MA in the presence of CMC was 
examined. Their mole ratios were varied to synthesize a series of CMC-g-P(MEO2MA-co-
OEOMA) copolymers with different amounts of hydrophobic MEO2MA units (see appendix B 
for detailed synthesis). DLS technique to follow the change in LS intensity was used to examine 
their thermal properties (Figure B.3). As seen in Figure 4.1, the phase transition temperature 
(called LCST) of CMC-g-P(MEO2MA-co-OEOMA) decreased from 57 to 29 ºC as the amount of 
hydrophobic MEO2MA units increased in grafted P(MEO2MA-co-OEOMA) from 0 to 75 mol%. 




Figure 4.1. LCST of CMC-g-P((MEO2MA-co-OEOMA) as a function of the amount of 
hydrophobic MEO2MA units. 
 
To synthesize crosslinked DuR-BNGs, the optimized procedure that allows for the synthesis 
of CMC-g-P(MEO2MA-co-OEOMA) with its LCST = 29 ºC was applied in the presence of 
OEODMA crosslinker. During the polymerization at 40 ºC, above the LCST, the 
thermoresponsive P(MEO2MA-co-OEOMA) chains grafted from CMC become hydrophobic 
thereby collapse with each other. Because CMC backbones retain hydrophilic at 40 ºC, the 
formed grafted chains tend to self-associate to form micelle-like aggregates; concurrently they 
are crosslinked in the presence of OEODMA crosslinkers, yielding well-defined DuR-BNGs with 
narrow size distribution through temperature-driven self-association assisted method.[262] 
The resulting DuR-BNGs were characterized for their thermal property as well as size and 
morphology by DLS and TEM techniques. The resulting DuR-BNGs exhibit LCST = 32 ºC at 4.6 
mg/mL (Figure B.4). The LCST is slightly greater than that (29 ºC) of the corresponding 
uncrosslinked CMC-g-P6 (Table B.1), which is presumably due to the introduction of OEODMA 
having relatively long hydrophilic OEO chains (#EO = 9.5) increasing the hydrophilicity of the 
DuR-BNGs. The size of DuR-BNGs was determined to be 10.5 nm in diameter by DLS and 
16.7±4.6 nm with spherical morphology by TEM (Figure 4.2). 















Figure 4.2. DLS diagram and TEM image (inset) of DuR-BNGs measured at 25 ºC.  
4.3.2 Prolonged colloidal stability and non-specific protein absorption 
Prolonged colloidal stability during blood circulation and after extravasation into tumor 
tissues (pH < 6.5) is an important property for tumor-targeting nanocarriers. Herein, two 
experiments were designed to examine colloidal stability of the resulting DuR-BNGs. In an 
experiment, DuR-BNGs were incubated in buffer solutions at different pH values of 5.5 and 7.0 
over time at room temperature. As seen in Figure 4.3, their diameter as measured by DLS did not 
significantly change over two weeks, suggesting excellent colloidal stability of DuR-BNGs in the 
range of pHs. In another set of experiment, DuR-BNGs were incubated with a typical serum 
protein: bovine serum albumin (BSA) at pH = 7.4 (mimic physiological conditions) as a model to 
test their non-specific interaction with serum proteins in vitro. Human serum albumin is one of 
the most abundant protein in blood serum and is found at concentrations ranging from 35 - 50 
g/L. Herein, two different amounts of BSA, as a model protein, at the wt ratio of DuR-
BNGs/BSA = 1/30 and 1/45 in PBS were examined. After 72 hrs, the DLS diagrams of the 
mixtures show monomodal distribution with diameter  7 nm and no occurrence of significant 
aggregation (Figure 4.4a). Furthermore, BCA assay was used to evaluate the non-specific 
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interaction of DuR-BNGs with BSA by quantifying the concentration of free BSA in the 
supernatants of DuR-BNGs/BSA mixtures after incubation of 48 and 72 hrs. A calibration curve 
was first constructed with absorbance at λ = 562 nm over BSA concentrations (Figure B.5). The 
curve was then used to determine the amount of free BSA within the supernatants. As seen in 
Figure 4.4b, DuR-BNGs exhibit no significant non-specific interactions with BSA. These results 
suggest that the DuR-BNGs based on biocompatible CMC and P(MEO2MA-co-OEOMA) are 
colloidally stable and enable preventing non-specific protein adsorption in physiological 
conditions.  
 
Figure 4.3. Evolution of diameter of DuR-BNGs in buffer solutions at pH = 5.5 and 7.0.  
  


















Figure 4.4. DLS diagrams of mixtures consisting of different wt ratios of DuR-BNG/BSA = 1/30 
(BSA = 30 mg/mL) (M-1) and 1/45 (BSA = 45 mg/mL) (M-2) in PBS at pH = 7.4 and after 72 
hrs (a) and the percentage of free BSA in supernatants at 48 and 72 hrs (b). 
4.3.3 Encapsulation of DOX 
To preliminarily evaluate the efficacy of DuR-BNGs as tumor-targeting drug delivery 
nanocarriers, DOX loaded DuR-BNGs were prepared by mixing an aqueous DOX stock solution 
with aqueous DuR-BNG dispersion. After the aqueous mixtures were incubated at 37 ºC (above 
LCST) for 24 hrs, they were then subjected to an intensive dialysis for 48 hrs. The removal of 
free (not encapsulated) DOX was monitored by the change in the UV absorbance of DOX at  = 
497 nm in outer water. Using an extinction coefficient of DOX = 10,000 M-1 cm-1 in water at  = 
497 nm,[263] the loading level = 2.5 ± 0.3 wt % and loading efficiency = 49.2 ± 5.8 % were 
determined at the initial wt ratio of DOX/DuR-BNGs = 1/20. 
4.3.4 Dual stimuli-responsive release of encapsulated DOX 
The enhanced release kinetics of encapsulated DOX from DOX-loaded DuR-BNGs in 
response to change in temperature and pH was investigated. DOX molecules released from DOX-
loaded DuR-BNGs diffuse out of dialysis tubing; the accumulative DOX in outer water was 
monitored by UV spectrometer with an external probe at  = 497 nm.  
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Temperature-responsive release was first examined for DOX-loaded DuR-BNGs in dialysis 
tubing incubated in KHP buffer (pH = 7) at different temperatures. As seen in Figure 4.5a, the 
amount of encapsulated DOX released from DOX-loaded DuR-BNGs gradually increased over 
time. Furthermore, DOX release was faster at temperatures above LCST. Such rapid release is 
attributed to the hydrophobic transition of thermoresponsive DuR-BNGs, which causes nanogel 
to shrink and aggregate, thus expelling the encapsulated DOX (Scheme 4.1). Interestingly, a burst 
release was observed in the initial time of release (mostly within 300 min). To get an insight into 
the thermoresponsive release of encapsulated DOX, the release kinetics in the early stage (within 
300 min) was investigated using Fickian’s diffusion model. Figure 4.5a is re-plotted with 
ln(Co/Ct) over time in Figure B.6, where Co is the initial concentration of DOX and Ct is its 
concentration at time t within dialysis bag. By fitting the data to linear regression, apparent 
diffusion constants (Dapp) were estimated to be 0.30/hr at 43 ºC, 0.20/hr at 40 ºC, 0.16/hr at 37 ºC 
and 0.06/hr at 25 ºC. The result suggests greater Dapp value at higher temperature. 
Given the enhanced release in response to higher temperature, acidic pH-responsive release 
of encapsulated DOX was investigated at 37 ºC. DOX release was monitored by immersing 
DOX-loaded DuR-BNGs in buffer at pH = 5.5 (mimic to cancer cell environment) and pH = 7 
(physiological condition). As seen in Figure 4.5b, DOX release was rapid at pH = 5.5, compared 
with pH = 7. The enhanced release at pH = 5.5 is attributed to less interactions between DOX and 
CMC. At neutral pH = 7, amine groups of DOX molecules exist in the protonated form (NH3+Cl− 
forms) because pKa of DOX = 8.3, while carboxylic acid groups on CMC exist in the anionic 
(COO-) form (note pKa of COOH = 4.3). Such electrostatic interactions between DOX and DuR-
BNGs slow down DOX release. However, at pH = 5.5 (close to the pKa of COOH), more 
carboxylic acid groups exist as their neutral form (COOH). This could decrease the electrostatic 
interactions between DOX and DuR-BNGs. Figure B.7 suggests that the change of ionic strength 




Figure 4.5. Release of DOX from DOX-loaded DuR-BNGs in aqueous buffer solution (pH = 7) at 
different temperatures of 25, 37, 40, and 43 ºC (a) and at pH = 5.5 and 7 (37 ºC) (b).   
4.3.5 Intracellular trafficking and antitumor activity of DOX-loaded DuR-BNGs 
Intracellular trafficking of DOX-loaded DuR-BNGs was investigated by flow cytometry and 
CLSM. Figure 4.6a shows the flow cytometric histograms of HeLa cells incubated with DOX-
loaded DuR-BNGs compared with free DOX and empty DuR-BNGs as controls. The amount of 
DOX in DOX-loaded DuR-BNGs was designed to be the same as free DOX. Histograms present 
noticeable elevated fluorescence intensity compared to empty DuR-BNGs. Figure 4.6b shows 
CLSM images of HeLa cells incubated with and without DOX-loaded DuR-BNGs for 5 hrs. For 
comparison, HeLa cells were also incubated with free DOX. HeLa nuclei were stained with 
DAPI. The cells nuclei show clear DOX fluorescence signal; this suggest that DOX was released 
from DOX-loaded DuR-BNGs to reach cell nuclei within 5 hrs. Notice that the fluorescence 
intensity of DOX from DOX-loaded DuR-BNGs is similar with free DOX. Taking into account 
both results, DuR-BNGs were able to deliver and rapidly release encapsulated DOX into cells 
and reach cells nuclei. 
































Figure 4.6. Flow cytometric histograms (a) and CLSM images of HeLa cells incubated with 
DuR-BNGs only (A), DOX-loaded DuR-BNGs (B), and free DOX (C) for 5 hrs (b). Scale bar = 
10 μm. 
 
In vitro cytotoxicity of Dox-free and DOX-loaded DuR-BNGs were evaluated by MTT 
colorimetric assay using HeLa cancer cells. As seen in Figure 4.7a, empty DuR-BNGs exhibit > 
90% of HeLa cell viability, suggesting non-toxicity of DuR-BNGs at concentrations up to 1.0 
mg/mL. In the presence of DOX-loaded DuR-BNGs, however, the viability of HeLa cells 
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decreased with an increasing amount of both free and encapsulated DOX (Figure 4.7b). 
Promisingly, the HeLa cell viability in the presence of DOX-loaded DuR-BNGs is competitive to 
that with free DOX at all concentrations tested in the experiment. This decrease in HeLa cell 
viability suggests the inhibition of cellular proliferation due to the effective and rapid release of 
DOX from DuR-BNGs.  
 
Figure 4.7. Viability of HeLa cells incubated with different amounts of DuR-BNGs only (a), 





We have synthesized dual temperature/acidic pH-responsive DuR-BNGs with narrow size 
distribution by a facile aqueous crosslinking polymerization assisted with temperature-driven 
self-association method. These well-defined nanogels had excellent colloidal stability at a broad 
pH range and in the presence of proteins in vitro. They exhibited enhanced release upon changes 
in their morphologies (volumes or ionic interactions) in response to individual stimuli including 
high temperature and acidic pH; furthermore the DuR-BNGs promoted synergic release of 
encapsulated anticancer drugs in the presence of both stimuli. Cell culture results from CLSM, 
flow cytometry, and MTT viability assay suggest intracellular release of anticancer drugs from 
DOX-loaded DuR-BNGs into HeLa cancer cells. These results suggest that new DuR-BNGs are a 





Chapter 5  
Conclusion and Future Work 
Polymer-based drug delivery systems have been explored to circumvent challenges facing 
small drugs: limited drug efficiency and side effects. In particular, naturally-occurring 
polysaccharides can be considered as promising building blocks in constructing drug delivery 
nanocarriers. Furthermore, nanocarriers that are able to undergo chemical or physical changes in 
response to external stimuli offer great opportunities for controlled release of encapsulated drugs. 
In this thesis, two types of dual stimuli-responsive polysaccharide-based BNGs were developed, 
and their applications toward tumor-targeting drug delivery were evaluated.  
First, well-defined pH/reduction-responsive CMC-based ssBNGs were synthesized by a 
facile aqueous crosslinking polymerization of OEOMA in the presence of CMC and a disulfide-
labeled crosslinker (ssDMA). The resulting ssBNGs had the diameter ≈ 25 nm confirmed by DLS 
and TEM. DOX was physically encapsulated within ssBNGs through electrostatic interactions. 
ssBNGs exhibit enhanced drug release in response to acidic pH due to a less interactions between 
DOX and ssBNGs, and reducing agent due to the reductive cleavage of disulfide bonds. 
Furthermore, their ability to facile conjugating with cell-targeting ligands was demonstrated 
using a water soluble UV-active dye as a model cell-targeting biomolecule.  
Second, the dual temperature/acidic pH-responsive DuR-BNGs were prepared by aqueous 
crosslinking polymerization assisted with temperature-driven self-association method, yielding 
narrow-size distribution of DuR-BNGs with diameter ≈ 11 nm. The DuR-BNGs had good 
colloidal stability in physiological and acidic pH conditions. For biological perspective, DuR-
BNGs show negligible non-specific protein absorption with model protein BSA for up to 72 hrs. 
In response to high temperature and acidic pH, DuR-BNGs underwent changes in volume or 
ionic interactions triggering rapid drug release. Potential applications toward drug delivery of two 
types of BNGs have been evaluated with MTT viability assay and cellular uptake test by CLSM 
and flow cytometry.  
In summary, the thesis presents different dual stimuli-responsive BNGs fabricated via 
aqueous crosslinking polymerization. Although they display promising features toward drug 
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delivery applications, further improvements are required toward effective tumor-targeting drug 
delivery applications. First of all, ssBNGs exhibited insignificant enhancement of DOX release in 
response to reducing agent possibly due to the low crosslink density of nanogel networks. In the 
meantime, the use of large amount of crosslinkers can lead to significant inter-particle 
crosslinking and aggregation. One potential solution is to introduce thiol (SH) groups into 
polysaccharide backbones. The pendant thiol groups will generate disulfide cross linkages 
through thiol-disulfide exchange reaction, thereby increasing the crosslink density of polymer 
networks.[118] Furthermore, the prepared BNGs display some premature drug release within 
physiological environment. The interaction between drug and polymer matrix plays a key role in 
determining the drug loading capacity and release profile.[264] Physically encapsulated drugs 
easily diffuse out of nanogel matrix causing leakage.[50] Chemically attached drug molecules 
avoid premature release, but they potentially suffer from slow drug release when the cleavage of 
labile linkage between drug and nanogel are slow or incomplete.[265] Therefore, further 
understanding is necessary to reduce premature drug release and achieve desirable 
pharmacokinetics. Finally, DuR-BNGs exhibited enhanced drug release at higher temperature, 
which makes them to be good candidates for hyperthermia treatment. New thermoresponsive 
BNGs that sensitive to small change in temperature will be highly desired since the temperature 
difference a human body can tolerate is very limited. Toward this goal, more work is needed to 
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I. Aqueous FRP of OEOMA without CMC 
A series of FRP of OEOMA in water were carried out under different conditions. As a 
typical example, the procedure to synthesize FRP-2 (Table A.1) under the conditions of OEOMA  
= 10 mg/mL and VA-44 = 2% of OEOMA at 40 C is described as follows; OEOMA (0.15 g, 
0.32 mmol) was dissolved in water (15 mL) in a 25 mL Schlenk flask. The resulting clear 
solution was purged with nitrogen for 30 min under magnetic stirring, and then heated to 40 C in 
a water bath for 10 min. A nitrogen-prepurged aqueous stock solution of VA-44 (0.3 mL, 10 
mg/mL, 9.3 mol) was added using a syringe to initiate the polymerization. For kinetic studies, 
samples were withdrawn at different time intervals during the polymerization to determine 
conversion by 1H-NMR. Polymerization was stopped by cooling down to room temperature. 
 
Kinetic studies of aqueous FRP of OEOMA  
A series of FRP of OEOMA in aqueous solution was carried out in the presence of a water-
soluble VA-44 azo-type free-radical initiator. VA-44 was selected because of its short half-life at 
lower temperature (τ1/2 = 10 hrs at 44 °C). Important parameters that influence the rate of aqueous 
FRP were examined; these parameters include the amount of VA-44 and temperature. For kinetic 
studies, aliquots withdrawn at given time intervals were analyzed for monomer conversion using 
1H-NMR in D2O. Table A.1 summarizes the results. First, the amount of VA-44 was varied at 40 
C. The rate of polymerization increased with an increasing amount of VA-44 in the mixture. For 
example, OEOMA conversion was 63% in the presence of 1 wt% VA-44 after 2 hrs (FRP-1). The 
conversion increased to 78% with 2 wt% VA-44 (FRP-2), and further to 83% with 3 wt% (FRP-
3) under similar conditions. However, molecular weight decreased when the amount of VA-44 
increased. Such decrease is attributed to the increase in flux of free radicals generated by thermal 
decomposition of VA-44 initiators. Next, the polymerization temperature decreased to 30 C in 
the presence of 2 wt% VA-44 (FRP-4). The conversion decreased from 78% to 67% by 
approximately 10%, compared to FRP-2 at 40 C. For all polymerization reactions, molecular 
weight distribution of the resulting POEOMA homopolymers was broad as Mw/Mn > 2.6, due to 
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polymerization being preceded in uncontrolled manner. These results suggest that the rate of 
polymerization is enhanced in the presence of larger amounts of initiator at higher temperatures. 
 
Table A.1. Characteristics and results for FRP of OEOMA in aqueous solution after 2 hrs.  




(C) Conv b) 
Mn c) 
(g/mol) Mw/Mn 
FRP-1 10 1 40 0.63 159,600 2.6 
FRP-2 10 2 40 0.78 115,000 3.3 
FRP-3 10 4 40 0.83 97,800 3.3 
FRP-4 10 2 30 0.67 120,000 3.2 
a) Wt% based on OEOMA; b) Determined by 1H-NMR in D2O; c) Determined by GPC. 
 
II. Aqueous FRP of OEOMA in the presence of CMC  
For the synthesis of POEOMA-g-CMC, similar procedure for aqueous FRP of OEOMA was 
conducted in the presence of CMC at 40 C. For an example of FRP-C1, CMC (0.15 g) and 
OEOMA (0.15 g, 0.32 mmol) were dissolved in water (15 mL) in 25mL Schlenk flask. The 
resulting clear solution was purged with nitrogen for 30 min under magnetic stirring and then 
heated to 40 C in a water bath for 10 min. A nitrogen-prepurged aqueous stock solution of VA-
44 (0.3 mL, 10 mg/mL, 9.3 mol) was added using a syringe to initiate the polymerization. 
Polymerization was stopped by cooling down to room temperature. 
 
Preparation of POEOMA-g-CMC  
The results of a series of FRP of OEOMA initiated with a water-soluble VA-44 azo-type 
free-radical initiator in aqueous solution are described. The optimized procedure was applied to 
the synthesis of POEOMA-grafted CMC (POEOMA-g-CMC). An aqueous FRP of OEOMA in 
the presence of CMC was conducted at 40 C under the conditions of OEOMA = 10 mg/mL, VA-
44 = 2 wt% on OEOMA, and OEOMA/CMC = 1/1 wt ratio (FRP-C1 in Table 3.1). Due to the 
high molecular weight of CMC, the viscosity of its aqueous solution strongly relies on the 
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concentration of CMC. It was found that 1 wt% aqueous CMC solution is suitable for FRP. For 
more than 10 repeated polymerization reactions, conversion reached 80.4 ± 4.3% on average after 
2 hrs. This value is similar to that (conv = 78%) without CMC (FRP-2 in Table A.1), suggesting 
no significant effect of the presence of CMC on the course of aqueous FRP under the conditions. 
DLS was used to measure the size and size distribution of the resulting POEOMA-g-CMC in 
water. As seen in Figure 3.1 (10 mg/mL), DLS trace shows multimodal size distribution with 
three populations; the major population of small sizes with an average diameter  23 nm and two 
minor populations of larger aggregates with average diameters  86 and 487 nm. These three 
populations resulted in the number average diameter, Dn = 32.5 ± 11.5 nm and relatively broad 
size distribution, Dw/Dn = 1.5. Such multimodal distribution with relatively high standard 
deviation could be attributed to inter-chain or inter-particle coupling reactions, resulting in the 
formation of undesired aggregates. 
The amount of OEOMA (as well as CMC) in the polymerization mixtures decreased from 10 
mg/mL to 2 mg/mL and further to 0 mg/mL (CMC only) for aqueous FRP at 40 C, while other 
parameters remained constant (OEOMA/CMC = 1/1 w/w and VA-44 = 0.2 mg/mL). Table A.2 
summarizes the characteristics and conversion data. For all polymerization, conversion reached 
as high as 80%; however, longer polymerization time was required when smaller amount of 
OEOMA was added. For example, FRP-C4 with 2 mg/mL OEOMA reached 81% conversion in 8 
hrs. DLS results indicate that the sizes of the resulting products prepared in the presence of 
OEOMA are larger than that (diameter = 1 nm) of CMC only in water, suggesting the occurrence 
of grafting POEOMA from CMC chains (Figure 3.1). Interestingly, their diameter decreased with 
a decreasing amount of OEOMA; 33 nm at 10 mg/mL (FRP-C1) to 20 nm at 6.7 mg/mL (FRP-
C2), and further to 9 nm at 2 mg/mL (FRP-C4). Polydispersity also decreased. These results 
suggest that the probability to inter-chain or inter-particle coupling reaction could decrease with 




Table A.2. Characteristics and results for aqueous FRP of OEOMA in the presence of CMC at 40 
C.a)  
Recipe OEOMA  (mg/mL) 
Time Convb) (hrs) 
FRP-C1 10 2 0.83 
FRP-C2 6.7 4 0.84 
FRP-C3 3.3 5 0.86 
FRP-C4 2 8 0.81 
a) VA-44 = 0.2 mg/mL, OEOMA/CMC = 1/1 wt/wt; b) Determined by 1H-NMR in D2O.  
 
Figure A.1. DLS diagrams of POEOMA synthesized by aqueous FRP with various 
concentrations of OEOMA in water ranging from 0 to 10 mg/mL. VA-44 = 0.2 wt% of OEOMA, 
T = 40 °C. 
 
  






Dn = 32.5 ± 11.2  nmDw/Dn = 1.4
Dn = 19.5 ± 3.5  nmDw/Dn = 1.33
Dn = 14.2 ± 2.4 nmDw/Dn = 1.3
Dn = 8.9 ± 2.2 nmDw/Dn = 1.2








III. Qualitative analysis of POEOMA-g-CMC  
 
Table A.3. Solubility test in various solvents at 5 mg/mL concentration.  
Solvent CMC POEOMA 
Water Dissolved Dissolved 
Acetone Undissolved Dissolved 
Ethanol: acetic acid (1:1 v/v) Undissolved Dissolved 
 
























IV. Loading of Dox   
Figure A.3. UV absorbance of free DOX in outer water during extensive dialysis at  = 497 nm. 
 
 
Figure A.4. Comparison of UV/Vis spectra of DOX-loaded ssBNGs (0.2 mg/mL) with free DOX 










































V. Bioconjugation for active targeting   




Figure A.6. UV/Vis spectra of (a) absorbance, (b) abs vs different concentrations of APTS in 


























































Synthesis and characterization of uncrosslinked CMC-g-P(MEO2MA-co-OEOMA)  
The synthesis of thermoresponsive CMC-grafted polymer (CMC-g-P(MEO2MA-co-
OEOMA)) was conducted by aqueous polymerization of two biocompatible methacrylates having 
different # of pedant EO units, MEO2MA and OEOMA, in the presence of CMC. A series of 
aqueous polymerization was initiated at 40 ºC by a water-soluble azo-type initiator (VA-44) with 
different feed ratios of MEO2MA/OEOMA. The results are summarized in Table B.1. Monomer 
conversion was determined by 1H-NMR spectroscopy using the integrals of the peak at 0.8-1.2 
ppm corresponding to 3 protons in methyl groups on polymers to the peak at 6.1 ppm 
corresponding to one proton in methacrylate groups of monomers (Figure B.1). All 
polymerization reached > 82% monomer conversion. After the purification by removal of 
unreacted monomers, the resulting copolymers were characterized by FT-IR technique. As seen 
in Figure B.2, the FT-IR spectrum of CMC-g-P6 shows two characteristic bands appearing at 
1605 cm-1 corresponding to carboxylate (C(=O)O-) anion absorption of CMC and at 1730 cm-1 
corresponding to ester C=O vibrational absorption of grafted P(MEO2MA-co-OEOMA) 
copolymers. Furthermore, DLS was used to determine particle size of copolymers in aqueous 
solutions 25 ºC. Their diameters ranged at 7-13 nm regardless of the amount of MEO2MA units 
in copolymers. 
 
Thermal properties of uncrosslinked CMC-g-P(MEO2MA-co-OEOMA)  
The thermoresponsive property of the resulting grafted CMC polymers were characterized 
using DLS. As seen in Figure S.3, a change in LS intensity of aqueous copolymer solutions was 
monitored as temperature increased from 20 to 90 ºC. At temperature above their LCST, 
thermoresponsive CMC-grafted copolymers collapsed to form aggregates, leading to a significant 
increase in LS intensity. Linear regression of the data points allowed for the determination of 
their LCST. As summarized in Table B.1, the LCST decreased from 57 to 29 ºC with an 




Table B.1. Characteristics of physical and thermal properties of CMC-g-P(MEO2MA-co-










CMC-g-P0 0  0.84 13 57 
CMC-g-P1 10  0.85 11 54 
CMC-g-P2  25 0.87 7 50 
CMC-g-P3  41 0.83 11 41 
CMC-g-P4  52  0.84 11 38 
CMC-g-P5  67 0.83 10 34 
CMC-g-P6 75 0.84 8 29 
a In feed composition of MEO2MA and OEOMA. b By 1H-NMR. c By DLS at 4.6 mg/mL at 25 
ºC.  d By DLS with temperature increase from 20 ºC to 90 ºC at an increment of 1 ºC /min.      
 










Figure B.2. FT-IR spectrum of CMC-g-P6 (CMC-g-P(MEO2MA-co-OEOMA)). 
 
 
Figure B.3. Temperature dependence of normalized light scattering intensity by DLS for aqueous 
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Figure B.4. Temperature dependence of normalized light scattering intensity by DLS for aqueous 
solutions of DuR-BNGs at 4.6 mg/mL. 
 
  
Figure B.5. Calibration curve to determine the concentration of BAS in PBS at pH = 7.4. Fitting 
function: y = 0.0384 + 0.0014x -2.40151E-7x2 (R2 = 0.99689). 
 

































Figure B.6. Release of DOX from DOX-loaded DuR-BNGs in aqueous buffer solution (pH = 
7.0) at various temperatures of 25, 37, 40, and 43 ºC. Apparent diffusion constant (Dapp) is 
determined from the slopes obtained by fitting the data to a linear regression. 
 
 
Figure B.7. Release of DOX from DOX-loaded DuR-BNGs in NaCl aqueous solution (pH = 7.0, 
T = 37 ºC) at different ionic strengths of 154 and 308 mM. 
 
  































List of publications 
K. Rahimian, Y. Wen, J. K. Oh.* Redox-responsive cellulose-based thermoresponsive 
grafted copolymers and in-situ disulfide crosslinked nanogels, Polymer 2015. 
Y. Wen, J. K. Oh.* Recent strategies to develop polysaccharide-based nanomaterials for 
biomedical applications, Macromolecular Rapid Communications 2014, 35, 1819-1832. 
Y. Wen, J. K. Oh.* Dual-stimuli reduction and acidic pH-responsive bionanogels: 
intracellular delivery nanocarriers with enhanced release, RSC Advances 2014, 4, 229-237. 
S. Aleksanian; Y. Wen; N. Chan; Jung Kwon Oh.* Tuning thermoresponsive kinetics of 
hydrogels with thiol-responsive degradation. RSC Advances 2014, 4, 3713. 
